
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Israel+Hanukoglu</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Israel+Hanukoglu"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Israel_Hanukoglu"/>
	<updated>2026-09-12T16:03:53Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2910134</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2910134"/>
		<updated>2018-06-08T14:39:38Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added a new reference&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;70/702915/Cv/1&#039; caption=&#039;Structure of adrenodoxin reductase with FAD and NADP. PDB ID: [[1e1k]].&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Adrenodoxin reductase&#039;&#039;&#039; (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a [[Rossmann fold]] that binds FAD and a central domain that binds NADPH.&amp;lt;ref&amp;gt;PMID:29177972&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Cv/12&#039;&amp;gt;Ball and stick repsentation of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Cv/11&#039;&amp;gt;Spacefill repsentation of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Cv/9&#039;&amp;gt;FAD binding site in AR&amp;lt;/scene&amp;gt; (water molecules shown as red spheres)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Cv/10&#039;&amp;gt;NADP binding site in AR&amp;lt;/scene&amp;gt; (water molecules shown as red spheres) (PDB entry [[1e1k]])&amp;lt;ref&amp;gt;PMID:10998235&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Fad_rossmann_fold/1&#039;&amp;gt;Rossmann fold of FAD&amp;lt;/scene&amp;gt; &lt;br /&gt;
{{clear}}&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
==3D Structures of Adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}&lt;br /&gt;
&lt;br /&gt;
[[1e1k]], [[1e1l]], [[1e1m]] – bADR+FAD+NADP – bovine&amp;lt;br /&amp;gt;&lt;br /&gt;
[[1e1n]], [[1cjc]] – bADR+FAD&amp;lt;br /&amp;gt;&lt;br /&gt;
[[1e6e]] – bADR + adrenodoxin&amp;lt;br /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
[[Category: Oxidoreductase]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;br /&gt;
[[Category:Topic Page]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:NAD-NADH-redox-reactions.png&amp;diff=2427842</id>
		<title>File:NAD-NADH-redox-reactions.png</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:NAD-NADH-redox-reactions.png&amp;diff=2427842"/>
		<updated>2015-08-16T10:09:51Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: uploaded a new version of &amp;quot;Image:NAD-NADH-redox-reactions.png&amp;quot;: This image shows the redox reactions of NAD together with the structures of the oxidized (NAD+) and reduced (NADH) forms.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This image shows the redox reactions of NAD together with the structures of the oxidized (NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;) and reduced (NADH) forms.&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=NADH&amp;diff=2427823</id>
		<title>NADH</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=NADH&amp;diff=2427823"/>
		<updated>2015-08-14T15:48:27Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==NAD (Nicotinamide Adenine Dinucleotide)==&lt;br /&gt;
Nicotinamide Adenine Dinucleotide (NAD) is a coenzyme that participates in electron transfer reactions. The oxidized form of NAD is abbreviated as NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; and it can accept two electrons. The reduced form of NAD is abbreviated as NADH.&lt;br /&gt;
&lt;br /&gt;
Equation for the redox reaction for these two forms of NAD: NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + 2H &amp;amp;rarr; NADH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:NAD-NADH-redox-reactions.png]]&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=NADH&amp;diff=2427822</id>
		<title>NADH</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=NADH&amp;diff=2427822"/>
		<updated>2015-08-14T15:47:02Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==NAD (Nicotinamide Adenine Dinucleotide)==&lt;br /&gt;
Nicotinamide Adenine Dinucleotide (NAD) is a coenzyme that participates in electron transfer reactions. The oxidized form of NAD is abbreviated as NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; and it can accept two electrons. The reduced form of NAD is abbreviated as NADH.&lt;br /&gt;
&lt;br /&gt;
Equation for the redox reaction for these two forms of NAD:&lt;br /&gt;
&lt;br /&gt;
NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + 2H &amp;amp;rarr; NADH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:NAD-NADH-redox-reactions.png]]&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:NAD-NADH-redox-reactions.png&amp;diff=2427821</id>
		<title>File:NAD-NADH-redox-reactions.png</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:NAD-NADH-redox-reactions.png&amp;diff=2427821"/>
		<updated>2015-08-14T15:44:52Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: This image shows the redox reactions of NAD together with the structures of the oxidized (NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;) and reduced (NADH) forms.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This image shows the redox reactions of NAD together with the structures of the oxidized (NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;) and reduced (NADH) forms.&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=NADH&amp;diff=2427820</id>
		<title>NADH</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=NADH&amp;diff=2427820"/>
		<updated>2015-08-14T13:48:20Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==NAD (Nicotinamide Adenine Dinucleotide)==&lt;br /&gt;
Nicotinamide Adenine Dinucleotide (NAD) is a coenzyme that participates in electron transfer reactions. The oxidized form of NAD is abbreviated as NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; and it can accept two electrons. The reduced form of NAD is abbreviated as NADH.&lt;br /&gt;
&lt;br /&gt;
Equation for the redox reaction for these two forms of NAD:&lt;br /&gt;
&lt;br /&gt;
NAD&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + 2H &amp;amp;rarr; NADH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=NADH&amp;diff=2427819</id>
		<title>NADH</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=NADH&amp;diff=2427819"/>
		<updated>2015-08-13T18:44:17Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Opened the page&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==NAD (Nicotinamide Adenine Dinucleotide)==&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2409156</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2409156"/>
		<updated>2015-06-06T22:53:20Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on the Rossmann fold has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot;&amp;gt;PMID:25704928&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 43:206-209, 2015.&lt;br /&gt;
&lt;br /&gt;
The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
As noted above, the Rossmann fold is associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first β-strand the α-helix.&lt;br /&gt;
The first two scenes demonstrate the location of the first two conserved glycines.&lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
As seen in the example in Fig. 5, the direction of the strands are all parallel. This represents a general trend in Rossmann folds. However in some Rossmann folds there may be some strands in anti-parallel direction.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As compared to the direction of the &amp;amp;beta;-strands, the direction of the helical segments is generally anti-parallel to the &amp;amp;beta;-strands (Fig. 5).&lt;br /&gt;
&lt;br /&gt;
In some Rossmann fold domains, the segments in between the &amp;amp;beta;-strands may include a complex series of helical and coiled segments (for example see [[3bhi]]).&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;br /&gt;
[[Category:Featured in BAMBED]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409155</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409155"/>
		<updated>2015-06-06T21:50:50Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a [[Rossmann fold]] that binds FAD and a central domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_cpk/1&#039;&amp;gt;CPK model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Fad_rossmann_fold/1&#039;&amp;gt;Rossmann fold of FAD&amp;lt;/scene&amp;gt;&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category: Oxidoreductase]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409154</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409154"/>
		<updated>2015-06-06T20:11:23Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Structure of adrenodoxin reductase */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a [[Rossmann fold]] that binds FAD and a central domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_cpk/1&#039;&amp;gt;CPK model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Fad_rossmann_fold/1&#039;&amp;gt;Rossmann fold of FAD&amp;lt;/scene&amp;gt;&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409153</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409153"/>
		<updated>2015-06-06T19:29:16Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a Rossmann fold that binds FAD and a C terminal domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_cpk/1&#039;&amp;gt;CPK model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Fad_rossmann_fold/1&#039;&amp;gt;Rossmann fold of FAD&amp;lt;/scene&amp;gt;&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409152</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409152"/>
		<updated>2015-06-06T19:00:09Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a Rossmann fold that binds FAD and a C terminal domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_cpk/1&#039;&amp;gt;CPK model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409151</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409151"/>
		<updated>2015-06-06T18:59:42Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a Rossmann fold that binds FAD and a C terminal domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_cpk/1&#039;&amp;gt;model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409150</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409150"/>
		<updated>2015-06-06T18:53:03Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a Rossmann fold that binds FAD and a C terminal domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/702915/Nadp_fad_ball_stick/1&#039;&amp;gt;Ball and stick model of NADP and FAD in AR&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409137</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409137"/>
		<updated>2015-06-05T14:53:24Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==Structure of adrenodoxin reductase==&lt;br /&gt;
&lt;br /&gt;
AR has two main domains. The N terminal domain contains a Rossmann fold that binds FAD and a C terminal domain that binds NADPH.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1e1k&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 1. Structure of adrenodoxin reductase with FAD and NADP. PDB ID: 1e1k.&#039; scene=&#039;&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409136</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409136"/>
		<updated>2015-06-05T14:26:22Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are expressed in cells that specialize in the biosynthesis and secretion of steroids. The reactions these systems catalyze include the first step in steroid hormone synthesis that is cleavage of the side chain of cholesterol producing pregnenolone, C11- hydroxylation of steroids producing glucocorticoids, C-18 hydroxylation of steroids leading to the synthesis of mineralocorticoids, and C-25 and C-27 hydroxylations of steroids in the pathways of bile acid and vitamin D synthesis.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The first two electron transfer proteins are shared by all systems. Substrate and reaction specificity of the system is dependent on the type of P450. &lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH which are transferred to FAD with the following stoichiometry:&lt;br /&gt;
&lt;br /&gt;
NADPH + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FAD → NADP&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; + FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&lt;br /&gt;
&lt;br /&gt;
After this initial transfer, AR catalyzes transfer of electron from FADH&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; to adrenodoxin in two independent steps as adrenodoxin is a single electron acceptor. Reduced adrenodoxin in turn transfers its electron to mitochondrial P450 during the complex catalytic cycle of P450. &lt;br /&gt;
&lt;br /&gt;
Thus, the route of electron transfer in these systems is as follows:&lt;br /&gt;
&lt;br /&gt;
NADPH &amp;amp;rarr; AR &amp;amp;rarr; adrenodoxin &amp;amp;rarr; P450&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=User:Israel_Hanukoglu&amp;diff=2409135</id>
		<title>User:Israel Hanukoglu</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=User:Israel_Hanukoglu&amp;diff=2409135"/>
		<updated>2015-06-04T18:44:03Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Pages that I have authored in Proteopedia */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Israel Hanukoglu, Ph.D.&lt;br /&gt;
&lt;br /&gt;
Professor of Biochemistry and Molecular Biology&lt;br /&gt;
&lt;br /&gt;
Faculty of Natural Sciences, Ariel University, Ariel, Israel&lt;br /&gt;
&lt;br /&gt;
Fields of expertise: Epithelial sodium channel, steroidogenic enzymes, keratin and intermediate filament structure, mitochondrial cytochromes P450&lt;br /&gt;
&lt;br /&gt;
Personal web site: http://www.science.co.il/hi/&lt;br /&gt;
&lt;br /&gt;
==Pages that I have authored in Proteopedia==&lt;br /&gt;
&lt;br /&gt;
[[Keratins]]&lt;br /&gt;
&lt;br /&gt;
[[Rossmann fold]]&lt;br /&gt;
&lt;br /&gt;
[[Adrenodoxin reductase]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409134</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409134"/>
		<updated>2015-06-04T18:41:48Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that functions as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in the biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
The enzyme nomenclature code of AR is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==Mitochondrial P450 systems==&lt;br /&gt;
Mitochondrial P450 systems are composed of three proteins: &lt;br /&gt;
* Adrenodoxin reductase&lt;br /&gt;
* Adrenodoxin, a [2Fe-2S] ferredoxin type iron-sulfur protein &lt;br /&gt;
* Mitochondrial P450&lt;br /&gt;
&lt;br /&gt;
The reactions catalyzed by P450 type enzymes are called monooxygenation reactions because P450 catalyzes incorporation of only one atom of molecular O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;  into substrate (S) while reducing the second atom of O into H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O with the following stoichiometry: &lt;br /&gt;
&lt;br /&gt;
SH + O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; + NAD(P)H + H&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;  &amp;amp;rarr;  ROH + H&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O + NAD(P)&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In the mitochondrial P450 systems, the source of electrons is NADPH. The main function of AR in these systems is to accept two electrons from NADPH and to transfer them one at time to adrenodoxin. Reduced adrenodoxin in turn reduces mitochondrial P450s that catalyze essential steps in the biosynthesis of steroids, such as cleavage of the side chain of cholesterol producing pregnenolone, and C11- and C18 hydroxylation steroids producing cortisol and aldosterone.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409133</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409133"/>
		<updated>2015-06-04T17:57:27Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that function as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; Its enzyme nomenclature code is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409132</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409132"/>
		<updated>2015-06-04T17:56:59Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is an FAD containing flavoprotein that function as an electron transfer protein in the mitochondrial P450 systems that catalyze essential steps in biosynthesis of steroid hormones.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt;. Its enzyme nomenclature code is [http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/18/1/6.html 1.18.1.6].&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409131</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2409131"/>
		<updated>2015-06-04T16:47:12Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Introduction&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Adrenodoxin reductase (AR) is the first enzyme in the mitochondrial P450 systems that are expressed in tissues that synthesize steroids.&amp;lt;ref name=&amp;quot;HI-review&amp;quot;&amp;gt;PMID:22217824&amp;lt;/ref&amp;gt; AR is an FAD containing flavoprotein that receives two electrons from NADPH and transfers them one at time to adrenodoxin that is an iron sulfur protein. Reduced adrenodoxin in turn reduces mitochondrial P450s that catalyze essential steps in the biosynthesis of steroids, such as pregnenolone, cortisol, aldosterone and sex steroids.&amp;lt;ref name=&amp;quot;HI-review&amp;quot; /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Highest_impact_structures&amp;diff=2409130</id>
		<title>Highest impact structures</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Highest_impact_structures&amp;diff=2409130"/>
		<updated>2015-06-04T16:18:38Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Highest Impact Macromolecular Structures of All Time */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Two Types of &amp;quot;Impact&amp;quot;==&lt;br /&gt;
&lt;br /&gt;
Macromolecular 3D structures can impact &#039;&#039;&#039;scientific understanding&#039;&#039;&#039; and/or &#039;&#039;&#039;save lives&#039;&#039;&#039; by contributing to [[Structure-based drug design]]. The first list below, [[#Highest Impact Macromolecular Structures of All Time|Highest Impact Macromolecular Structures of All Time]], concerns impact on scientific understanding. A separate list below concerns [[#Structures Saving The Most Lives|Structures Saving The Most Lives]].&lt;br /&gt;
&lt;br /&gt;
==Highest Impact Macromolecular Structures of All Time==&lt;br /&gt;
&lt;br /&gt;
Below you are invited to list pages about structures that you believe to be among the highest impact since the first empirical macromolecular structures were determined. Please do &#039;&#039;&#039;not&#039;&#039;&#039; list a structure unless you &#039;&#039;provide a justification in the form of a brief description of its impact&#039;&#039;. &lt;br /&gt;
&lt;br /&gt;
More about some of the earliest structures and their PDB files is [http://www.umass.edu/microbio/rasmol/1st_xtls.htm here]. &lt;br /&gt;
&lt;br /&gt;
This list is in chronological order.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1953 - [[DNA]] double helix&#039;&#039;&#039; (B form): Although Watson and Crick&#039;s model was theoretical, it was essentially correct, and for the first time explained the ability of genes to be faithfully copied during cell division. It was not confirmed by atomic resolution X-ray crystallography until 1973, using RNA dinucleotide crystals. A full turn of B form DNA was not solved until 1980 (cf. [[1bna]]), 27 years after Watson and Crick&#039;s model. More: click on DNA at the [http://atlas.molviz.org Atlas of Macromolecules]&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1958 - [[Myoglobin]]&#039;&#039;&#039;: As the first protein structure that was determined, it is hard to exaggerate its impact. Before this structure, proteins were widely believed to be colloidal, and protein crystals were expected to contain highly symmetrical structures. The irregular fold of myoglobin (see photo of an early low-resolution model at [[Nobel Prizes for 3D Molecular Structure]]) was a huge surprise.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1965 - Lysozyme&#039;&#039;&#039;: The first enzyme crystal structure determination and the third protein structure overall. The structure provided the first view of a beta-sheet, and the first view of the three-dimensional arrangement of catalytic amino acid residues in an active site.&amp;lt;ref&amp;gt;Lysozyme: A model enzyme in protein crystallography. NCJ Strynadka and MNG James in&lt;br /&gt;
Lysozymes: Model Enzymes in Biochemistry and Biology By Pierre Jollès, Birkhäuser, 1996&lt;br /&gt;
ISBN 3764351217&amp;lt;/ref&amp;gt; An inhibitor-bound structure determined in the same year showed the non-covalent interactions between binding cleft and the ligand. Lysozyme is a model enzyme for studying crystallization, the impact of crystal packing on structure, catalytic activity in the crystalline state, and the consequences of mutations on structure and activity. (See [[lysozyme]].)&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1970 - Deoxy-hemoglobin&#039;&#039;&#039;: M. Perutz&#039; second hemoglobin structure proved to be at least as important as the first, published two years earlier, as it demonstrated that a protein can have several conformations, and that its physiological role depends on how it changes from one to the other.  (See [[Hemoglobin]].)&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1974 - [[tRNA|Transfer RNA]]&#039;&#039;&#039;: The first 3D RNA structure solved; tRNA remained the only biological RNA solved crystallographically for around two decades. This landmark structure served as a foundation for our understanding of RNA structure and translation in general&amp;lt;ref&amp;gt;PMID: 11504628&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1978 - Tobacco bushy stunt virus&#039;&#039;&#039;: S. Harrison offered the first atomic scale image of a complete biological object, a plant virus. It was a technical feat, and revealed rules of architecture that, a few years later (1985), were shown to apply to human pathogens such as the common cold and the poliomyelitis viruses. &lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1983 - [[Keratin]]&#039;&#039;&#039;: Israel Hanukoglu determined the primary structures and predicted secondary structures of type and type II keratins as a postdoc in the lab of Elaine Fuchs at the University of Chicago.&amp;lt;ref&amp;gt;PMID:6191871&amp;lt;/ref&amp;gt; His analyses served as models for all intermediate family proteins, and were confirmed by crystallography of soluble keratin fragments nearly 30 years later.&amp;lt;ref&amp;gt;PMID:22705788&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1987 - [[Major_Histocompatibility_Complex_Class_I | Major histocompatibility complex class I]]&#039;&#039;&#039;: Created a paradigm shift in cellular immunology by explaining how MHC is involved in presenting hidden intracellular proteins to T lymphocytes. During the decade prior to this structure, this was a constantly debated but very murky mystery.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;2000 - [[Ribosome]]&#039;&#039;&#039;: This structure surprised almost everyone by showing that peptidyl transferase is a ribozyme, rather than a protein enzyme. It won the [[Nobel_Prizes_for_3D_Molecular_Structure#Twenty-First_Century|2009 Nobel Prize in Chemistry]].&lt;br /&gt;
* &#039;&#039;&#039;2007 and 2011 - [[G protein-coupled receptor]]&#039;&#039;&#039;: In 2007 the structure of the first ligand-activated G protein-coupled receptor and in 2011 the first activated G protein-coupled receptor bound to its G protein.  This is a large class of proteins that have great importance as targets for drug development; it is estimated that 4% of the human genome devoted to protein coding encodes this class of proteins.   The determination of the structures lead to Brian Kobilika sharing the [[Nobel_Prizes_for_3D_Molecular_Structure#Twenty-First_Century|2012 Nobel Prize in Chemistry]]&lt;br /&gt;
&lt;br /&gt;
==Structures Saving The Most Lives==&lt;br /&gt;
&lt;br /&gt;
Structures of the following molecules were used in [[Structure-based drug design|structure-based drug design]], and the resulting drugs have saved large numbers of lives.&lt;br /&gt;
&lt;br /&gt;
* [[Avian Influenza Neuraminidase, Tamiflu and Relenza|Influenza virus neuraminidase structure]] was used in designing the neuraminidase inhibitors [[Avian Influenza Neuraminidase, Tamiflu and Relenza|oseltamivir (Tamiflu&amp;amp;reg;) and zanamivir (Relenza&amp;amp;reg;)]]. Roche, the manufacturer of Tamiflu, estimates that 50 million people have been treated with this drug&amp;lt;ref&amp;gt;[http://www.roche.com/med-cor-2007-04-26 Roche update on Tamiflu for pandemic influenza preparedness], Media Release, April 26, 2007.&amp;lt;/ref&amp;gt;.  The [http://en.wikipedia.org/wiki/Cochrane_Collaboration Cochrane Collaboration] concluded that neuriminidase inhibitors &amp;quot;are effective in preventing and treating the symptoms and complications of influenza&amp;quot;&amp;lt;ref&amp;gt;[http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001265/frame.html Neuraminidase inhibitors for preventing and treating influenza in healthy adults], T. Jefferson &#039;&#039;et al.&#039;&#039;, Cochrane Database of Systematic Reviews, Issue 4, 2008. DOI [http://dx.doi.org/10.1002/14651858.CD001265.pub2 10.1002/14651858.CD001265.pub2]&amp;lt;/ref&amp;gt;. Influenza kills hundreds of thousands of people annually&amp;lt;ref&amp;gt;[http://en.wikipedia.org/wiki/Influenza Influenza] in Wikipedia.&amp;lt;/ref&amp;gt;, including 40,000 in the United States&amp;lt;ref&amp;gt;[http://aje.oxfordjournals.org/cgi/content/full/163/2/181 Mortality due to Influenza in the United States—An Annualized Regression Approach Using Multiple-Cause Mortality Data], J. Dushoff &#039;&#039;et al.&#039;&#039;, Am. J. Epidemiol. 163:181-7, 2006.&amp;lt;/ref&amp;gt;. While it is difficult to estimate accurately the number of lives saved by these drugs, the number seems likely to be very large.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
* [[HIV-1_protease|HIV protease structure]] was used in designing [http://en.wikipedia.org/wiki/Protease_inhibitor_(pharmacology) anti-retroviral protease inhibitors] that, as a component of [http://en.wikipedia.org/wiki/Antiretroviral_drug Highly Active Anti-Retroviral Therapy (HAART)], have added many high-quality years to the lives of HIV infected individuals. While HAART greatly extends life in HIV infected patients, it is not a cure, and these patients may eventually succumb to AIDS. For more, please see [[User:Eric_Martz/Molecular_Playground/HIVDrug|AIDS Before Protease Inhibitors &amp;amp; HIV Protease Inhibitors: A Breakthrough]].&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
*[http://www.umass.edu/microbio/rasmol/1st_xtls.htm Earliest Solutions for Macromolecular Crystal Structures]&lt;br /&gt;
*[[Personal favorites]]&lt;br /&gt;
*[http://www.molecularstructure.org/ Structural Biology Rankings] ranks 3D structures according to their popularity among scientists and citation count.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Highest_impact_structures&amp;diff=2409129</id>
		<title>Highest impact structures</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Highest_impact_structures&amp;diff=2409129"/>
		<updated>2015-06-04T16:17:53Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Highest Impact Macromolecular Structures of All Time */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Two Types of &amp;quot;Impact&amp;quot;==&lt;br /&gt;
&lt;br /&gt;
Macromolecular 3D structures can impact &#039;&#039;&#039;scientific understanding&#039;&#039;&#039; and/or &#039;&#039;&#039;save lives&#039;&#039;&#039; by contributing to [[Structure-based drug design]]. The first list below, [[#Highest Impact Macromolecular Structures of All Time|Highest Impact Macromolecular Structures of All Time]], concerns impact on scientific understanding. A separate list below concerns [[#Structures Saving The Most Lives|Structures Saving The Most Lives]].&lt;br /&gt;
&lt;br /&gt;
==Highest Impact Macromolecular Structures of All Time==&lt;br /&gt;
&lt;br /&gt;
Below you are invited to list pages about structures that you believe to be among the highest impact since the first empirical macromolecular structures were determined. Please do &#039;&#039;&#039;not&#039;&#039;&#039; list a structure unless you &#039;&#039;provide a justification in the form of a brief description of its impact&#039;&#039;. &lt;br /&gt;
&lt;br /&gt;
More about some of the earliest structures and their PDB files is [http://www.umass.edu/microbio/rasmol/1st_xtls.htm here]. &lt;br /&gt;
&lt;br /&gt;
This list is in chronological order.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1953 - [[DNA]] double helix&#039;&#039;&#039; (B form): Although Watson and Crick&#039;s model was theoretical, it was essentially correct, and for the first time explained the ability of genes to be faithfully copied during cell division. It was not confirmed by atomic resolution X-ray crystallography until 1973, using RNA dinucleotide crystals. A full turn of B form DNA was not solved until 1980 (cf. [[1bna]]), 27 years after Watson and Crick&#039;s model. More: click on DNA at the [http://atlas.molviz.org Atlas of Macromolecules]&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1958 - [[Myoglobin]]&#039;&#039;&#039;: As the first protein structure that was determined, it is hard to exaggerate its impact. Before this structure, proteins were widely believed to be colloidal, and protein crystals were expected to contain highly symmetrical structures. The irregular fold of myoglobin (see photo of an early low-resolution model at [[Nobel Prizes for 3D Molecular Structure]]) was a huge surprise.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1965 - Lysozyme&#039;&#039;&#039;: The first enzyme crystal structure determination and the third protein structure overall. The structure provided the first view of a beta-sheet, and the first view of the three-dimensional arrangement of catalytic amino acid residues in an active site.&amp;lt;ref&amp;gt;Lysozyme: A model enzyme in protein crystallography. NCJ Strynadka and MNG James in&lt;br /&gt;
Lysozymes: Model Enzymes in Biochemistry and Biology By Pierre Jollès, Birkhäuser, 1996&lt;br /&gt;
ISBN 3764351217&amp;lt;/ref&amp;gt; An inhibitor-bound structure determined in the same year showed the non-covalent interactions between binding cleft and the ligand. Lysozyme is a model enzyme for studying crystallization, the impact of crystal packing on structure, catalytic activity in the crystalline state, and the consequences of mutations on structure and activity. (See [[lysozyme]].)&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1970 - Deoxy-hemoglobin&#039;&#039;&#039;: M. Perutz&#039; second hemoglobin structure proved to be at least as important as the first, published two years earlier, as it demonstrated that a protein can have several conformations, and that its physiological role depends on how it changes from one to the other.  (See [[Hemoglobin]].)&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1974 - [[tRNA|Transfer RNA]]&#039;&#039;&#039;: The first 3D RNA structure solved; tRNA remained the only biological RNA solved crystallographically for around two decades. This landmark structure served as a foundation for our understanding of RNA structure and translation in general&amp;lt;ref&amp;gt;PMID: 11504628&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1978 - Tobacco bushy stunt virus&#039;&#039;&#039;: S. Harrison offered the first atomic scale image of a complete biological object, a plant virus. It was a technical feat, and revealed rules of architecture that, a few years later (1985), were shown to apply to human pathogens such as the common cold and the poliomyelitis viruses. &lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1983 - Keratin&#039;&#039;&#039;: Israel Hanukoglu determined the primary structures and predicted secondary structures of type and type II keratins as a postdoc in the lab of Elaine Fuchs at the University of Chicago.&amp;lt;ref&amp;gt;PMID:6191871&amp;lt;/ref&amp;gt; His analyses served as models for all intermediate family proteins, and were confirmed by crystallography of soluble keratin fragments nearly 30 years later.&amp;lt;ref&amp;gt;PMID:22705788&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;1987 - [[Major_Histocompatibility_Complex_Class_I | Major histocompatibility complex class I]]&#039;&#039;&#039;: Created a paradigm shift in cellular immunology by explaining how MHC is involved in presenting hidden intracellular proteins to T lymphocytes. During the decade prior to this structure, this was a constantly debated but very murky mystery.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;2000 - [[Ribosome]]&#039;&#039;&#039;: This structure surprised almost everyone by showing that peptidyl transferase is a ribozyme, rather than a protein enzyme. It won the [[Nobel_Prizes_for_3D_Molecular_Structure#Twenty-First_Century|2009 Nobel Prize in Chemistry]].&lt;br /&gt;
* &#039;&#039;&#039;2007 and 2011 - [[G protein-coupled receptor]]&#039;&#039;&#039;: In 2007 the structure of the first ligand-activated G protein-coupled receptor and in 2011 the first activated G protein-coupled receptor bound to its G protein.  This is a large class of proteins that have great importance as targets for drug development; it is estimated that 4% of the human genome devoted to protein coding encodes this class of proteins.   The determination of the structures lead to Brian Kobilika sharing the [[Nobel_Prizes_for_3D_Molecular_Structure#Twenty-First_Century|2012 Nobel Prize in Chemistry]]&lt;br /&gt;
&lt;br /&gt;
==Structures Saving The Most Lives==&lt;br /&gt;
&lt;br /&gt;
Structures of the following molecules were used in [[Structure-based drug design|structure-based drug design]], and the resulting drugs have saved large numbers of lives.&lt;br /&gt;
&lt;br /&gt;
* [[Avian Influenza Neuraminidase, Tamiflu and Relenza|Influenza virus neuraminidase structure]] was used in designing the neuraminidase inhibitors [[Avian Influenza Neuraminidase, Tamiflu and Relenza|oseltamivir (Tamiflu&amp;amp;reg;) and zanamivir (Relenza&amp;amp;reg;)]]. Roche, the manufacturer of Tamiflu, estimates that 50 million people have been treated with this drug&amp;lt;ref&amp;gt;[http://www.roche.com/med-cor-2007-04-26 Roche update on Tamiflu for pandemic influenza preparedness], Media Release, April 26, 2007.&amp;lt;/ref&amp;gt;.  The [http://en.wikipedia.org/wiki/Cochrane_Collaboration Cochrane Collaboration] concluded that neuriminidase inhibitors &amp;quot;are effective in preventing and treating the symptoms and complications of influenza&amp;quot;&amp;lt;ref&amp;gt;[http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001265/frame.html Neuraminidase inhibitors for preventing and treating influenza in healthy adults], T. Jefferson &#039;&#039;et al.&#039;&#039;, Cochrane Database of Systematic Reviews, Issue 4, 2008. DOI [http://dx.doi.org/10.1002/14651858.CD001265.pub2 10.1002/14651858.CD001265.pub2]&amp;lt;/ref&amp;gt;. Influenza kills hundreds of thousands of people annually&amp;lt;ref&amp;gt;[http://en.wikipedia.org/wiki/Influenza Influenza] in Wikipedia.&amp;lt;/ref&amp;gt;, including 40,000 in the United States&amp;lt;ref&amp;gt;[http://aje.oxfordjournals.org/cgi/content/full/163/2/181 Mortality due to Influenza in the United States—An Annualized Regression Approach Using Multiple-Cause Mortality Data], J. Dushoff &#039;&#039;et al.&#039;&#039;, Am. J. Epidemiol. 163:181-7, 2006.&amp;lt;/ref&amp;gt;. While it is difficult to estimate accurately the number of lives saved by these drugs, the number seems likely to be very large.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
* [[HIV-1_protease|HIV protease structure]] was used in designing [http://en.wikipedia.org/wiki/Protease_inhibitor_(pharmacology) anti-retroviral protease inhibitors] that, as a component of [http://en.wikipedia.org/wiki/Antiretroviral_drug Highly Active Anti-Retroviral Therapy (HAART)], have added many high-quality years to the lives of HIV infected individuals. While HAART greatly extends life in HIV infected patients, it is not a cure, and these patients may eventually succumb to AIDS. For more, please see [[User:Eric_Martz/Molecular_Playground/HIVDrug|AIDS Before Protease Inhibitors &amp;amp; HIV Protease Inhibitors: A Breakthrough]].&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
*[http://www.umass.edu/microbio/rasmol/1st_xtls.htm Earliest Solutions for Macromolecular Crystal Structures]&lt;br /&gt;
*[[Personal favorites]]&lt;br /&gt;
*[http://www.molecularstructure.org/ Structural Biology Rankings] ranks 3D structures according to their popularity among scientists and citation count.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2409105</id>
		<title>Sandbox 1pjs</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2409105"/>
		<updated>2015-06-03T15:46:56Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;Structure load=&#039;1pjs&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/703460/Nad-domain/1&#039;&amp;gt;NAD binding domain&amp;lt;/scene&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2409103</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2409103"/>
		<updated>2015-06-03T14:53:20Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Extension of the beta sheet by additional strands */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on the Rossmann fold has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot;&amp;gt;PMID:25704928&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 43:206-209, 2015.&lt;br /&gt;
&lt;br /&gt;
The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
As seen in the example in Fig. 5, the direction of the strands are all parallel. This represents a general trend in Rossmann folds. However in some Rossmann folds there may be some strands in anti-parallel direction.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As compared to the direction of the &amp;amp;beta;-strands, the direction of the helical segments is generally anti-parallel to the &amp;amp;beta;-strands (Fig. 5).&lt;br /&gt;
&lt;br /&gt;
In some Rossmann fold domains, the segments in between the &amp;amp;beta;-strands may include a complex series of helical and coiled segments (for example see [[3bhi]]).&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;br /&gt;
[[Category:Featured in BAMBED]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2407557</id>
		<title>Sandbox 1pjs</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2407557"/>
		<updated>2015-06-02T10:58:27Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;Structure load=&#039;1pjs&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;70/703460/Nad-domain/1&#039;&amp;gt;TextToBeDisplayed&amp;lt;/scene&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2407551</id>
		<title>Sandbox 1pjs</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_1pjs&amp;diff=2407551"/>
		<updated>2015-06-02T10:14:25Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: New page: &amp;lt;Structure load=&amp;#039;1pjs&amp;#039; size=&amp;#039;500&amp;#039; frame=&amp;#039;true&amp;#039; align=&amp;#039;right&amp;#039; caption=&amp;#039;Insert caption here&amp;#039; scene=&amp;#039;Insert optional scene name here&amp;#039; /&amp;gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;Structure load=&#039;1pjs&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2407509</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2407509"/>
		<updated>2015-06-01T18:18:27Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Noted that the beta strands in Rossmann folds are generally all parallel.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on the Rossmann fold has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot;&amp;gt;PMID:25704928&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 43:206-209, 2015.&lt;br /&gt;
&lt;br /&gt;
The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
As seen in the example in Fig. 5, the direction of the strands are all parallel. This represents a general trend in Rossmann folds. However in some Rossmann folds there may be some strands in anti-parallel direction.&amp;lt;ref name=&amp;quot;Hanukoglu-2015&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;br /&gt;
[[Category:Featured in BAMBED]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2405938</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2405938"/>
		<updated>2015-05-27T09:57:01Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3rec&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;Escherichia coli reca protein-bound DNA (PDB entry [[3rec]])&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
[[Adrenodoxin reductase 3D structures]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2405930</id>
		<title>Adrenodoxin reductase</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Adrenodoxin_reductase&amp;diff=2405930"/>
		<updated>2015-05-27T09:54:38Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Adrenodoxin reductase moved to Adrenodoxin reductase 3D structures&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#REDIRECT [[Adrenodoxin reductase 3D structures]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2405808</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2405808"/>
		<updated>2015-05-21T10:44:45Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added Category:Featured in BAMBED&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on the Rossmann fold has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref&amp;gt;PMID:25704928&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 43:206-209, 2015.&lt;br /&gt;
&lt;br /&gt;
The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;br /&gt;
[[Category:Featured in BAMBED]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2405807</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2405807"/>
		<updated>2015-05-21T10:39:38Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added reference to paper in BAMBED&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on the Rossmann fold has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref&amp;gt;PMID:25704928&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 43:206-209, 2015.&lt;br /&gt;
&lt;br /&gt;
The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049710</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049710"/>
		<updated>2014-11-03T15:11:52Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Contact region between Rossmann fold and FAD */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at the &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049709</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049709"/>
		<updated>2014-11-03T15:02:09Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Proteopedia includes a list of over 1,000 PDB structures with [[:Category:Rossmann fold | Rossmann fold]]. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049708</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049708"/>
		<updated>2014-11-03T14:57:07Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category: Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Category:Rossmann_fold&amp;diff=2049342</id>
		<title>Category:Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Category:Rossmann_fold&amp;diff=2049342"/>
		<updated>2014-11-02T17:38:29Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added link to Rossmann fold&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;List of pages with the keyword [[Rossmann fold]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Introduction_to_protein_structure&amp;diff=2049341</id>
		<title>Introduction to protein structure</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Introduction_to_protein_structure&amp;diff=2049341"/>
		<updated>2014-11-02T17:35:23Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Levels of Protein Structure ==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;1A3N&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;Structure of Hemoglobin (PDB entry [[1A3N]])&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
This tutorial illustrates some basic properties of protein structure and useful commands in Jmol and Proteopedia.  Clicking the green links changes the view in the structure box to illustrate the principle described by the text.  If the structure box has a puzzle piece in it, please make sure you have the latest version of [[Java]] installed and follow the directions to allow Proteopedia to run.&lt;br /&gt;
&lt;br /&gt;
Proteins are condensation polymers of amino acids.  The &amp;lt;scene name=&#039;57/575866/Primary_sequence/2&#039;&amp;gt;primary structure&amp;lt;/scene&amp;gt; is the amino acid sequence.  The &amp;lt;scene name=&#039;57/575866/Secondary_sequence/1&#039;&amp;gt;secondary structure&amp;lt;/scene&amp;gt; is the local structure over short distances.  This level of structure is stabilized by &amp;lt;scene name=&#039;57/575866/H_bond_a_helix/1&#039;&amp;gt;hydrogen bonds&amp;lt;/scene&amp;gt; along the &amp;lt;scene name=&#039;57/575866/Backbone/1&#039;&amp;gt;backbone&amp;lt;/scene&amp;gt;.  These secondary structures &amp;lt;scene name=&#039;57/575866/Global_secondary_structures/1&#039;&amp;gt;pack together&amp;lt;/scene&amp;gt; to form the overall form of the entire peptide chain, called the &amp;lt;scene name=&#039;57/575866/Tertiary/1&#039;&amp;gt;tertiary structure&amp;lt;/scene&amp;gt;.  Some proteins, such as the displayed hemoglobin molecule, have more than one polypeptide chain that associate to form the functional unit of the protein; this is called &amp;lt;scene name=&#039;57/575866/Tertiary/2&#039;&amp;gt;quaternary structure&amp;lt;/scene&amp;gt;.&lt;br /&gt;
&#039;&#039;&#039;Questions based upon these scenes:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
What is the primary sequence shown in the first link?&lt;br /&gt;
&lt;br /&gt;
Is the secondary structure shown an alpha helix or beta sheet?&lt;br /&gt;
&lt;br /&gt;
The ith C=O of the backbone is hydrogen bonded to which N(-H) (use i +/- # to represent the number)?&lt;br /&gt;
&lt;br /&gt;
What atom does this program NOT show?&lt;br /&gt;
&lt;br /&gt;
What color is used to represent alpha helices?&lt;br /&gt;
&lt;br /&gt;
How many alpha helices are present in the single peptide chain shown?&lt;br /&gt;
&lt;br /&gt;
How many polypeptide chains make up the quaternary structure?&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Ways of representing protein structure ==&lt;br /&gt;
Protein structures can be displayed in many different ways.  In &amp;lt;scene name=&#039;57/575866/Spacefill_segment/1&#039;&amp;gt;spacefilling&amp;lt;/scene&amp;gt; models, all of the non-hydrogen atoms are shown as spheres with their van der Waals radii.  In the &amp;lt;scene name=&#039;57/575866/Ball_and_stick_segment/1&#039;&amp;gt;ball and stick&amp;lt;/scene&amp;gt; model, the atoms are shown as smaller balls, connected by sticks; this is further simplified in the &amp;lt;scene name=&#039;57/575866/Stick_segment/1&#039;&amp;gt;stick&amp;lt;/scene&amp;gt; model, which only shows the bonds between atoms.  &amp;lt;scene name=&#039;57/575866/Backbone/2&#039;&amp;gt;Backbone&amp;lt;/scene&amp;gt; shows only the N-Calpha-C=O repeating unit; the &amp;lt;scene name=&#039;57/575866/Cartoon/4&#039;&amp;gt;cartoon&amp;lt;/scene&amp;gt; representation shows the secondary structures. &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Questions based upon these scenes:&#039;&#039;&#039;&lt;br /&gt;
Which of these representations would be best for showing...&lt;br /&gt;
&lt;br /&gt;
--the secondary structures present in a molecule?&lt;br /&gt;
&lt;br /&gt;
--Channels, holes, or pockets in a protein?&lt;br /&gt;
&lt;br /&gt;
--Residues in the active site of an enzyme?&lt;br /&gt;
&lt;br /&gt;
Explain your answers.&lt;br /&gt;
&lt;br /&gt;
== Secondary Structures ==&lt;br /&gt;
In this section, you will both learn about secondary structure properties and manipulating structures in Jmol.  We will begin with some basic manipulation strategies so that you can analyze secondary structures.  Try the following manipulations with the mouse:&lt;br /&gt;
--Click and move the mouse to the right, the left, up, and down; what happens to the molecule?&lt;br /&gt;
--Hold the shift button while you try the same manipulations.  What does each do?&lt;br /&gt;
&lt;br /&gt;
Clicking the right mouse button in the structure box brings up an extensive menu. This exercise will use commands in the style, color,zoom, measurements, and set picking categories.&lt;br /&gt;
&lt;br /&gt;
We will begin with the &amp;lt;scene name=&#039;57/575866/Cartoon/4&#039;&amp;gt;cartoon&amp;lt;/scene&amp;gt; structure of an alpha helix from hemoglobin.  From this view, can you determine:&lt;br /&gt;
--The number of amino acids per turn?&lt;br /&gt;
&lt;br /&gt;
--The position of the side chains?&lt;br /&gt;
&lt;br /&gt;
Hold the mouse over each end of the alpha helix.  A yellow box should appear, with [VAL]17:A:CA:#120.  This indicates the amino acid residue, the position in the chain, which chain, what atom it is (CA means the alpha carbon), and the overall number of the atom.  If there are two identical chains, one of the chains may be numbered slightly differently (like adding 200 to each residue number) to distinguish the residues.&lt;br /&gt;
--What is the amino acid range (numbers) of this alpha helix?&lt;br /&gt;
&lt;br /&gt;
Rotate the helix so that you are looking down the helix.  What does the middle of the helix look like?&lt;br /&gt;
Right click on the mouse, choose style, then scheme, then CPK spacefill. &lt;br /&gt;
&lt;br /&gt;
What does the middle of the helix look like?  &lt;br /&gt;
Which view is more representative of the true structure of the molecule?&lt;br /&gt;
&lt;br /&gt;
Let&#039;s try changing to another view.  Right click on the mouse, choose style, then scheme, then ball and stick.  Based upon what you know about peptide composition or by holding the mouse over the atoms determine the color scheme:&lt;br /&gt;
red = &lt;br /&gt;
&lt;br /&gt;
black = &lt;br /&gt;
&lt;br /&gt;
blue = &lt;br /&gt;
&lt;br /&gt;
Notice that hydrogens are not shown on this model.  Xray crystallography is not able to resolve hydrogens, so they are omitted from the images.  This also simplifies the data set, as there are many fewer atoms to position.&lt;br /&gt;
&lt;br /&gt;
Jmol can be used to make measurements of various properties of the alpha helix, such as the dihedral angle.  &amp;lt;scene name=&#039;57/575866/No_sidechains/1&#039;&amp;gt;This structure&amp;lt;/scene&amp;gt; has the side chains removed (though the alpha carbons show where the side chain would be).  Right click in the structure box.  In the Measurements menu, select &amp;quot;double click begins and ends measurements&amp;quot;.  Double click on one of the nitrogens, then click once on the following atoms in order:  the attached Calpha, carbonyl C, and N.  Record this dihedral angle (a psi angle) in a table, recording the number of the Calpha.  Repeat, starting at the N you ended on.  Notice each click gives a different property:  the first is the bond length, the second is the bond angle, and the third is the dihedral (torsional) angle.  You may need to rotate around the helix to see the atoms you want to measure; repeat for four psi angles. After you have completed it for the psi angles, repeat for the phi angles by clicking on the carbonyl C, Calpha, N and carbonyl C.  If you are having problems making the measurements, here is one with the &amp;lt;scene name=&#039;57/575866/No_sidechains/2&#039;&amp;gt;psi angles&amp;lt;/scene&amp;gt; and one with the &amp;lt;scene name=&#039;57/575866/Phi_angles/1&#039;&amp;gt;phi angles&amp;lt;/scene&amp;gt;.  &lt;br /&gt;
&lt;br /&gt;
What is the average phi angle in this alpha helix?  What is the range of values?&lt;br /&gt;
What is the average psi angle in this alpha helix?  What is the range?&lt;br /&gt;
&lt;br /&gt;
Since hemoglobin doesn&#039;t have any beta sheets, we will switch to another protein:  &amp;lt;scene name=&#039;57/575866/1cyo_rainbow/1&#039;&amp;gt;cytochrome B5&amp;lt;/scene&amp;gt;, PDB code 1CYO. &lt;br /&gt;
&lt;br /&gt;
Which rendering (spacefill, ball and stick, etc) is presented in this scene?  &lt;br /&gt;
&lt;br /&gt;
The coloring in this view is a N--&amp;gt;C rainbow, with the N terminus being blue and the C terminus red.&lt;br /&gt;
&lt;br /&gt;
Describe the relative positioning of the alpha helices and beta sheets.  Are all the alpha helices clustered with the beta sheets in another portion of the sequence, or are they interspersed?&lt;br /&gt;
&lt;br /&gt;
Next, we will look at two of the &amp;lt;scene name=&#039;57/575866/1cyo_20_32_transparent/1&#039;&amp;gt;beta strands&amp;lt;/scene&amp;gt;. The side chains have been faded out to make the backbone more obvious.&lt;br /&gt;
&lt;br /&gt;
Determine if these two strands are parallel or antiparallel.&lt;br /&gt;
&lt;br /&gt;
Where are the side chains positioned, relative to the main direction of the strand?&lt;br /&gt;
&lt;br /&gt;
Like before, measure four &amp;lt;scene name=&#039;57/575866/1cyo_20_32_psi/1&#039;&amp;gt;psi&amp;lt;/scene&amp;gt; and four &amp;lt;scene name=&#039;57/575866/1cyo_20_32_phi/1&#039;&amp;gt;phi&amp;lt;/scene&amp;gt; angles.   Record these values in a table.&lt;br /&gt;
&lt;br /&gt;
What is the average psi angle?  What is the range of values?&lt;br /&gt;
&lt;br /&gt;
What is the average phi angle?  What is the range of values?&lt;br /&gt;
&lt;br /&gt;
Which has more variability in the dihedral angles, an alpha helix or a beta sheet?&lt;br /&gt;
&lt;br /&gt;
The overall dihedral angles in a protein can be displayed in a &amp;lt;scene name=&#039;57/575866/Ramachandran/1&#039;&amp;gt;Ramachandran plot&amp;lt;/scene&amp;gt;, which graphs the interrelationship between phi and psi angles.  Pink dots are angles found in alpha helices; yellow dots are found in beta sheets, and white dots are found in other regions (either disordered or turns).  Mouse over the white dots on the right sides; what  amino acids tend to have atypical phi and psi angles?&lt;br /&gt;
&lt;br /&gt;
===Turns and loops===&lt;br /&gt;
Secondary structures are often connected by turns and loops, such as:&amp;lt;UL&amp;gt;&lt;br /&gt;
&amp;lt;LI&amp;gt;&#039;&#039;&#039;&amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Secondary_structure_betaturn/1&#039;&amp;gt;Beta Turns&amp;lt;/scene&amp;gt;&#039;&#039;&#039; - originally defined by the one hydrogen bond common to all (an i, i+3 hydrogen bond) but some modern descriptions do not require a hydrogen bond. &lt;br /&gt;
&amp;lt;LI&amp;gt;&#039;&#039;&#039;Alpha turns&#039;&#039;&#039; - the simplest of all motifs and is characterized by one (i, i+4) hydrogen bond. It is found as part of the hydrogen bonding network of alpha helices as well as occurring on its own.&lt;br /&gt;
&amp;lt;LI&amp;gt;&#039;&#039;&#039;&amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Secondary_structure_paperclip/1&#039;&amp;gt;Paperclip/Schellman Motifs&amp;lt;/scene&amp;gt;&#039;&#039;&#039; - a common motif found at the C-termini of alpha helices which is essentially a reverse turn that breaks the alpha helix out of its cycle. It is characterized by the presence of a left handed residue and two hydrogen bonds: an i, i+3 bond and an i, i+5 bond. &lt;br /&gt;
 &lt;br /&gt;
&amp;lt;/UL&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Motifs In Proteins==&lt;br /&gt;
A motif is a super-secondary structure; it describes a set of secondary structures that plays a functional or structural role in a protein.  The term is also used to describe a conserved amino acid sequence that characterizes a biochemical function.  &lt;br /&gt;
&lt;br /&gt;
One of the most common and widely distributed motifs is the [[Rossmann fold]] that appears in dinucleotide binding proteins.&lt;br /&gt;
&lt;br /&gt;
Another example is the &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_highlight/1&#039;&amp;gt;zinc finger motif&amp;lt;/scene&amp;gt; that is readily identified by the following consensus sequence pattern (where &amp;quot;X&amp;quot; represents &#039;&#039;any&#039;&#039; amino acid):&amp;lt;br/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cys&#039;&#039;&#039; - X&amp;lt;sub&amp;gt;(2-4)&amp;lt;/sub&amp;gt; - &#039;&#039;&#039;Cys&#039;&#039;&#039; - X&amp;lt;sub&amp;gt;(3)&amp;lt;/sub&amp;gt; - Phe - X&amp;lt;sub&amp;gt;(5)&amp;lt;/sub&amp;gt; - Leu - X&amp;lt;sub&amp;gt;(2)&amp;lt;/sub&amp;gt; - &#039;&#039;&#039;His&#039;&#039;&#039; - X&amp;lt;sub&amp;gt;(3)&amp;lt;/sub&amp;gt; - &#039;&#039;&#039;His&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
The example structure shown is that of Zif268 protein-DNA complex from Mus musculus (PDB entry 1AAY). In this example (a C2H2 class zinc finger) the conserved &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_cysteine/1&#039;&amp;gt;cysteine&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_histidine/2&#039;&amp;gt;histidine&amp;lt;/scene&amp;gt; residues form ligands to a &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_zn/1&#039;&amp;gt;zinc ion&amp;lt;/scene&amp;gt; whose coordination is essential to stabilise the tertiary fold of the protein. The fold is important because it helps orientate the &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_recognition/1&#039;&amp;gt;recognition helices&amp;lt;/scene&amp;gt; to bind to the &amp;lt;scene name=&#039;User:James_D_Watson/Structural_Templates/Zinc_finger_major_groove/1&#039;&amp;gt;major groove of the DNA&amp;lt;/scene&amp;gt;. &lt;br /&gt;
{{Clear}}&lt;br /&gt;
&lt;br /&gt;
==Domain==&lt;br /&gt;
A domain is an independently folded region of a protein that has a particular function.  In contrast to motifs, domains can exist as separate, functional proteins.  Often domains of proteins have different functions.  For example, [[glyceraldehyde-3-phosphate dehydrogenase]] has &amp;lt;scene name=&#039;57/575866/G3pd_domains/1&#039;&amp;gt;two domains&amp;lt;/scene&amp;gt;:  a NAD+ binding domain and a glyceraldehyde-3-phosphate binding domain.  The NAD binding domain is found in many proteins that bind NAD+, even though the reactions they catalyze are very different.&lt;br /&gt;
&lt;br /&gt;
==Tertiary Structure==&lt;br /&gt;
&lt;br /&gt;
The tertiary structure of a protein is the overall folding of a single polypeptide chain.  While we are still understanding the folding process, it is obvious that part of the driving force is the sequestering of hydrophobic residues to the middle of the protein, while polar residues are found on the surface.  In &amp;lt;scene name=&#039;57/575866/1cyo_hydrophobic/2&#039;&amp;gt;this representation&amp;lt;/scene&amp;gt;, the hydrophilic residues are purple, while the hydrophobic ones are grey.  While some hydrophobic residues are on the surface, they do not dominate the structure.  Disulfide bonds can also help stabilize the tertiary structure.&lt;br /&gt;
&lt;br /&gt;
==Quaternary structure==&lt;br /&gt;
The &amp;lt;scene name=&#039;57/575866/Tertiary/2&#039;&amp;gt;quaternary structure&amp;lt;/scene&amp;gt; of proteins is formed when polypeptide chains associate with one another to form a functional unit.  This allows for additional regulatory strategies.  Hemoglobin is the classic example of a quaternary protein structure, and you can explore more on the [[Hemoglobin]] page.  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Content Donators&#039;&#039;&#039;==&lt;br /&gt;
Created with content from [[Structural Templates]] written by [[User:Alexander Berchansky|Alexander Berchansky]], [[User:James D Watson|James D Watson], [[User:Eran Hodis|Eran Hodis]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Proteopedia:Structure_Index&amp;diff=2049336</id>
		<title>Proteopedia:Structure Index</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Proteopedia:Structure_Index&amp;diff=2049336"/>
		<updated>2014-11-02T17:26:16Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added Rossmann fold&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Each page in this Structure Index contains an organized list of PDB entries for a given macromolecule, as well as a brief description of the macromolecule itself. &lt;br /&gt;
&lt;br /&gt;
This Index is maintained manually and so is inevitably incomplete.  Those entries which are &amp;lt;font color=&#039;red&#039;&amp;gt;&amp;lt;b&amp;gt;red&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are coming soon. Please be sure to use the [[Help:Searching|search slots at the left]] if you don&#039;t find what you are looking for below.&lt;br /&gt;
&lt;br /&gt;
Updated:  {{REVISIONDAY2}}-{{REVISIONMONTH}}-{{REVISIONYEAR}} (DD-MM-YYYY)&lt;br /&gt;
[[Image: Picture_15.png|520px|right|thumb]]&lt;br /&gt;
{{#tree:id=PDBTree| openlevels=0|&lt;br /&gt;
** #&lt;br /&gt;
*** [[14-3-3 protein]]&lt;br /&gt;
*** [[2-Oxoglutarate Dehydrogenase]]&lt;br /&gt;
*** [[3-phosphoinositide-dependent protein kinase 1]] (Pdk1)&lt;br /&gt;
*** [[3C protease]]&lt;br /&gt;
*** [[4-hydroxy-3-methylbut-2-enyl diphosphate reductase]] (IspH)&lt;br /&gt;
*** [[5&#039;-deoxy-5&#039;-methylthioadenosine phosphorylase]] (MTAP)&lt;br /&gt;
*** [[6-aminohexanoate-dimer hydrolase]]&lt;br /&gt;
*** [[6-deoxyerythronolide B synthase (DEBS)]]&lt;br /&gt;
*** [[6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase]] (HPPK)&lt;br /&gt;
*** [[6-phosphogluconate dehydrogenase]]&lt;br /&gt;
*** [[7,8-diaminopelargonic acid synthetase]] (DAPAS)&lt;br /&gt;
*** [[7,8-dihydro-8-oxoguanine triphosphatase]]&lt;br /&gt;
** A&lt;br /&gt;
*** [[A Disintegrin And Metalloproteinase|A Disintegrin And Metalloproteinase (ADAM)]]&lt;br /&gt;
*** [[ABC transporter]] (ATP Binding Cassette transporter)&lt;br /&gt;
*** [[Acetyl-CoA carboxylase]]&lt;br /&gt;
*** [[Acetyl-CoA synthetase]]&lt;br /&gt;
*** [[Acetyl-CoA synthase]]&lt;br /&gt;
*** [[Acetylcholine binding protein]] (AChBP)&lt;br /&gt;
*** [[Acetylcholinesterase#Selected_3D_Structures_of_AChE|Acetylcholinesterase]] (AChE)&lt;br /&gt;
*** [[Acetylxylan esterase]]&lt;br /&gt;
*** [[Acid-beta-glucosidase]]&lt;br /&gt;
*** [[Acid phosphatase]]&lt;br /&gt;
*** [[Aconitase]] &lt;br /&gt;
*** [[Actin]]&lt;br /&gt;
*** [[Actinin]]&lt;br /&gt;
*** [[Acyl carrier protein]]&lt;br /&gt;
*** [[Acyl carrier protein synthase]]&lt;br /&gt;
*** [[Acyl-CoA dehydrogenase]]&lt;br /&gt;
*** [[Acylaminoacyl peptidase]]&lt;br /&gt;
*** [[Adapter molecule crk]] (Crk)&lt;br /&gt;
*** [[Adaptin]]&lt;br /&gt;
*** [[Adenine glycosylase]] (MutY)&lt;br /&gt;
*** [[Adenosine A2A receptor]]&lt;br /&gt;
*** [[Adenosine deaminase]] (ADA)&lt;br /&gt;
*** [[Adenosine dimethyltransferase]] (KsgA)&lt;br /&gt;
*** [[Adenosine kinase]]&lt;br /&gt;
*** [[Adenylate kinase]]&lt;br /&gt;
*** [[Adenylosuccinate Synthetase]]&lt;br /&gt;
*** [[Adenylyl cyclase]] &lt;br /&gt;
*** [[ADP-ribose pyrophosphatase]]&lt;br /&gt;
*** [[ADP-ribosyl cyclase]]&lt;br /&gt;
*** [[Adrenergic receptor]]&lt;br /&gt;
*** [[Adrenodoxin]]&lt;br /&gt;
*** [[Adrenodoxin reductase]]&lt;br /&gt;
*** [[Aerolysin]]&lt;br /&gt;
*** [[Agrin]]&lt;br /&gt;
*** [[Alanine racemase]]&lt;br /&gt;
*** [[Albumin]]&lt;br /&gt;
*** [[Alcohol dehydrogenase]]&lt;br /&gt;
*** [[Aldehyde dehydrogenase]]&lt;br /&gt;
*** [[Aldolase]]&lt;br /&gt;
*** [[Aldose Reductase]]&lt;br /&gt;
*** [[Alkaline phosphatase]]&lt;br /&gt;
*** [[Allophycocyanin]]&lt;br /&gt;
*** [[Alpha-1-antitrypsin]]&lt;br /&gt;
*** [[Alpha-glucosidase]]&lt;br /&gt;
*** [[Alpha-lytic protease]]&lt;br /&gt;
*** [[Alpha-parvin]]&lt;br /&gt;
*** [[Amino acid oxidase]]&lt;br /&gt;
*** [[Aminoacyl tRNA Synthetase]] &lt;br /&gt;
*** [[Aminopeptidase]]&lt;br /&gt;
*** [[AMP-activated protein kinase]]&lt;br /&gt;
*** [[Amylase]]&lt;br /&gt;
*** [[Amyloid precursor protein]] (APP)&lt;br /&gt;
*** [[Androgen receptor]] (AR)&lt;br /&gt;
*** [[Angiotensin-Converting_Enzyme#Additional_3D_Structures_of_ACE|Angiotensin-Converting Enzyme (ACE)]]&lt;br /&gt;
*** [[Ankyrin]]&lt;br /&gt;
*** [[Annexin]] &lt;br /&gt;
*** [[Anthrax edema factor]]&lt;br /&gt;
*** [[Anthrax Lethal Factor]]&lt;br /&gt;
*** [[Anthrax protective antigen]]&lt;br /&gt;
*** [[Anti-silencing factor]]&lt;br /&gt;
*** [[Antibody#Additional_3D_Structures_of_the_Immunoglobulin|Antibody]] or [[Monoclonal_Antibody#Additional_3D_Structures_of_Selected_Therapeutic_Monoclonal_Antibodies|Monoclonal Antibody]]&lt;br /&gt;
*** [[Antifreeze protein]]&lt;br /&gt;
*** [[Antithrombin]]&lt;br /&gt;
*** [[Antizyme Inhibitor]]&lt;br /&gt;
*** [[Apurinic-Apyrimidinic Endonuclease-1]]&lt;br /&gt;
*** [[Aquaporin]] &lt;br /&gt;
*** [[Arabinanase]]&lt;br /&gt;
*** [[Arginase]]&lt;br /&gt;
*** [[Arginine repressor]] (ArgR)&lt;br /&gt;
*** [[Argonaute]]&lt;br /&gt;
*** [[Aromatic amine dehydrogenase]] (AADH)&lt;br /&gt;
*** [[Arsenate reductase]]&lt;br /&gt;
*** [[Arylamine N-acetyltransferase]]&lt;br /&gt;
*** [[Ascorbate peroxidase]]&lt;br /&gt;
*** [[Asparaginase]]&lt;br /&gt;
*** [[Aspartate Aminotransferase]]&lt;br /&gt;
*** [[Aspartate-semialdehyde dehydrogenase]]&lt;br /&gt;
*** [[Aspartate carbamoyltransferase]] (ACTase)&lt;br /&gt;
*** [[Aspartate decarboxylase]]&lt;br /&gt;
*** [[Aspartoacylase]]&lt;br /&gt;
*** [[Atlastin]]&lt;br /&gt;
*** [[ATP Phosphoribosyl Transferase]]&lt;br /&gt;
*** [[ATP-citrate synthase]]&lt;br /&gt;
*** [[ATPase]]&lt;br /&gt;
*** [[Avidin]]&lt;br /&gt;
*** [[Avirulence protein]]&lt;br /&gt;
*** [[Axin]]&lt;br /&gt;
*** [[Azurin]]&lt;br /&gt;
** B&lt;br /&gt;
*** [[Bacteriophage repressor]]&lt;br /&gt;
*** [[Bacteriorhodopsin]]&lt;br /&gt;
*** [[BAG protein]] (Bcl-2 associated anthanogene)&lt;br /&gt;
*** [[BamHI]] (&#039;&#039;Bacillus amyloliquefaciens&#039;&#039; HI)&lt;br /&gt;
*** [[Barnase]]&lt;br /&gt;
*** [[Barstar]]&lt;br /&gt;
*** [[Basic Pancreatic Trypsin Inhibitor]] (BPTI) &lt;br /&gt;
*** [[Bcl-2]] (B cell lymphoma 2)&lt;br /&gt;
*** [[Beta-1,4-galactanase]]&lt;br /&gt;
*** [[Beta-2 microglobulin]]&lt;br /&gt;
*** [[Beta-glucosidase]]&lt;br /&gt;
*** [[Beta-Hexosaminidase|Beta-hexosaminidase]]&lt;br /&gt;
*** [[Beta-hydroxyacyl-acyl carrier protein dehydratase]] (FabZ, FabA)&lt;br /&gt;
*** [[Beta-lactamase]]&lt;br /&gt;
*** [[Beta-lactoglobulin]]&lt;br /&gt;
*** [[Beta-phosphoglucomutase]]&lt;br /&gt;
*** [[Beta secretase|Beta-secretase]] (BACE)&lt;br /&gt;
*** [[Bile acid receptor]] (FXR)&lt;br /&gt;
*** [[Biotin carboxylase]]&lt;br /&gt;
*** [[Biotin Protein Ligase]]&lt;br /&gt;
*** [[Blue copper oxidase CueO]]&lt;br /&gt;
*** [[BtuB]]&lt;br /&gt;
*** [[Bungarotoxin]]&lt;br /&gt;
*** [[Butyrylcholinesterase]]&lt;br /&gt;
** C&lt;br /&gt;
*** [[Ca2+/Calmodulin dependent protein kinase]] (CaMK)&lt;br /&gt;
*** [[Cadherin]]&lt;br /&gt;
*** [[Calcineurin]]&lt;br /&gt;
*** [[Calcium-dependent protein kinase]] (CDPK)&lt;br /&gt;
*** [[Calmodulin]]&lt;br /&gt;
*** [[Calpain]]&lt;br /&gt;
*** [[CAMP-dependent protein kinase]]&lt;br /&gt;
*** [[Canine parvovirus]]&lt;br /&gt;
*** [[Carbamoyl phosphate synthetase]]&lt;br /&gt;
*** [[Carbon monoxide dehydrogenase]]&lt;br /&gt;
*** [[Carbonic anhydrase]]&lt;br /&gt;
*** [[Carbonyl reductase]]&lt;br /&gt;
*** [[Carboxylesterase]]&lt;br /&gt;
*** [[Carboxypeptidase]]&lt;br /&gt;
*** [[Cardiotoxin]]‎&lt;br /&gt;
*** [[Carnitine acetyltransferase]]&lt;br /&gt;
*** [[Carnitine palmitoyltransferase]]&lt;br /&gt;
*** [[Casein kinase]]&lt;br /&gt;
*** [[Caspase]]&lt;br /&gt;
*** [[Catabolite control protein]] (CcpA)&lt;br /&gt;
*** [[Catabolite gene activator protein]]&lt;br /&gt;
*** [[Catalase]]&lt;br /&gt;
*** [[Catechol O-methyltransferase]]&lt;br /&gt;
*** [[Catenin]]&lt;br /&gt;
*** [[Cathepsin]]&lt;br /&gt;
*** [[CCA-adding enzyme]]&lt;br /&gt;
*** [[CD1]]&lt;br /&gt;
*** [[CD2]]&lt;br /&gt;
*** [[CD2-associated protein]]&lt;br /&gt;
*** [[CD3]]&lt;br /&gt;
*** [[CD4]]&lt;br /&gt;
*** [[CD8]]&lt;br /&gt;
*** [[CD38]]&lt;br /&gt;
*** [[CD44]]&lt;br /&gt;
*** [[CD47]]&lt;br /&gt;
*** [[CD59]]&lt;br /&gt;
*** [[CD69]]&lt;br /&gt;
*** [[C-di-GMP specific phosphodiesterases]]&lt;br /&gt;
*** [[Cell death protein]] (PD)&lt;br /&gt;
*** [[Cell division protein Ftsz]]&lt;br /&gt;
*** [[Cell Division Protein Kinase 2|Cell Division Protein Kinase 2 (CDK2)]]&lt;br /&gt;
*** [[Cellobiohydrolase]]&lt;br /&gt;
*** [[Cellular retinoic acid-binding protein]]&lt;br /&gt;
*** [[Centromere protein]] (CENP)&lt;br /&gt;
*** [[Cephalosporin acylase]]&lt;br /&gt;
*** [[Ceruloplasmin]]&lt;br /&gt;
*** [[Chaperonin]]&lt;br /&gt;
*** [[Chemotaxis protein]]&lt;br /&gt;
*** [[Chemotaxis receptor methyltransferase]]&lt;br /&gt;
*** [[Chitinase-3-like protein 1]]&lt;br /&gt;
*** [[Chitinase]]&lt;br /&gt;
*** [[Chloramphenicol acetyltransferase]] (CAT)&lt;br /&gt;
*** [[Cholera toxin]]&lt;br /&gt;
*** [[Cholesterol esterase]]&lt;br /&gt;
*** [[Cholesterol oxidase]]&lt;br /&gt;
*** [[Choline kinase]]&lt;br /&gt;
*** [[Choline O-acetyltransferase]]&lt;br /&gt;
*** [[Choline Oxidase]]&lt;br /&gt;
*** [[Chromodomain-helicase-DNA-binding protein]]&lt;br /&gt;
*** [[Chymotrypsin]]&lt;br /&gt;
*** [[Chymotrypsin Inhibitor]]&lt;br /&gt;
*** [[Circadian clock protein]]&lt;br /&gt;
*** [[Citrate Synthase]]&lt;br /&gt;
*** [[C-JUN]]&lt;br /&gt;
*** [[Clathrin]]&lt;br /&gt;
*** [[Clp Protease]]&lt;br /&gt;
*** [[ClpX]]&lt;br /&gt;
*** [[Cluster of Differentiation]] (CD)&lt;br /&gt;
*** [[C-Myc]]&lt;br /&gt;
*** [[Cobra venom factor]]&lt;br /&gt;
*** [[Cocaine esterase]]&lt;br /&gt;
*** [[Coenzyme A-Disulfide Reductase]]&lt;br /&gt;
*** [[Colicin]]&lt;br /&gt;
*** [[Colicin I receptor]]&lt;br /&gt;
*** [[Colicin Immunity Protein]]&lt;br /&gt;
*** [[Collagen]]&lt;br /&gt;
*** [[Collagenase (non-MMP)]]&lt;br /&gt;
*** [[Colonization factor antigen]]&lt;br /&gt;
*** [[Complement factor H]]&lt;br /&gt;
*** [[Complexin]]&lt;br /&gt;
*** [[Concanavalin A]]&lt;br /&gt;
*** [[Copper Amine Oxidase]]&lt;br /&gt;
*** [[Copper homeostasis protein]]&lt;br /&gt;
*** [[Corticosteroid-binding globulin]]&lt;br /&gt;
*** [[CotA laccase]]&lt;br /&gt;
*** [[Cowpea Chlorotic Mottle Virus]]&lt;br /&gt;
*** [[Creatine Kinase]]&lt;br /&gt;
*** [[CREB-binding protein]] (cAMP-Response Element-Binding protein)&lt;br /&gt;
*** [[Crotamine]]&lt;br /&gt;
*** [[Cruzain]]&lt;br /&gt;
*** [[Crystalline]]&lt;br /&gt;
*** [[CutA1]]&lt;br /&gt;
*** [[Cutinase]]&lt;br /&gt;
*** [[CXC chemokine receptor type 4| CXC chemokine receptor type 4 (CXCR4)]] &lt;br /&gt;
*** [[Cyclic GMP-AMP synthase]]&lt;br /&gt;
*** [[Cyclin]]&lt;br /&gt;
*** [[Cyclin-dependent kinase]] (CDK)&lt;br /&gt;
*** [[Cyclohydrolase]]&lt;br /&gt;
*** [[Cyclooxygenase]] (COX)&lt;br /&gt;
*** [[Cyclophilin]]&lt;br /&gt;
*** [[Cytidine monophosphate kinase]]&lt;br /&gt;
*** [[Cytochrome b5]]&lt;br /&gt;
*** [[Cytochrome bc1 complex]]&lt;br /&gt;
*** [[Cytochrome c]]&lt;br /&gt;
*** [[Cytochrome c oxidase]]&lt;br /&gt;
*** [[Cytochrome c peroxidase]]&lt;br /&gt;
*** [[Cytochrome f]]&lt;br /&gt;
*** [[Cytochrome P450]]&lt;br /&gt;
*** [[C-X-C motif chemokine]]&lt;br /&gt;
** D&lt;br /&gt;
*** [[D-alanine-D-alanine ligase]]&lt;br /&gt;
*** [[D-aminoacylase]]&lt;br /&gt;
*** [[Deaminase]]&lt;br /&gt;
*** [[Death-associated protein]]&lt;br /&gt;
*** [[Death-associated protein kinase]]&lt;br /&gt;
*** [[Defensin]]&lt;br /&gt;
*** [[Dehalogenase]]&lt;br /&gt;
*** [[Dehaloperoxidase]]&lt;br /&gt;
*** [[Dehydroquinase]]&lt;br /&gt;
*** [[Delta-endotoxin]]&lt;br /&gt;
*** [[Dendrotoxin]]&lt;br /&gt;
*** [[Deoxycytidine kinase]] (dCK)&lt;br /&gt;
*** [[Deoxyuridine 5&#039;-triphosphate nucleotidohydrolase]]&lt;br /&gt;
*** [[Dethiobiotin synthetase]]&lt;br /&gt;
*** [[Dihydrodipicolinate synthase]]&lt;br /&gt;
*** [[Dihydrofolate reductase]] (DHFR)&lt;br /&gt;
*** [[Dihydrolipoamide acetyltransferase]]&lt;br /&gt;
*** [[Dihydrolipoamide dehydrogenase]]&lt;br /&gt;
*** [[Dihydroorotate dehydrogenase]]&lt;br /&gt;
*** [[Dihydropteroate synthase]] (DHPS)&lt;br /&gt;
*** [[Dioxygenase ]] &lt;br /&gt;
*** [[Dipeptidyl peptidase]]&lt;br /&gt;
*** [[Diphtheria toxin]] &lt;br /&gt;
*** [[Diphtheria toxin repressor]] (DtxR)&lt;br /&gt;
*** [[Diphthine synthase]]&lt;br /&gt;
*** [[Disintegrin]]&lt;br /&gt;
*** [[Forms of DNA|DNA, A-, B- and Z- forms]]&lt;br /&gt;
*** [[DNA damage-binding protein]]&lt;br /&gt;
*** [[DNA glycosylase]]&lt;br /&gt;
*** [[DNA ligase]]&lt;br /&gt;
*** [[DNA methyltransferase]] (DNMT)&lt;br /&gt;
*** [[DNA polymerase]]&lt;br /&gt;
*** [[DnaA]]&lt;br /&gt;
*** [[DnaC helicase loader]]&lt;br /&gt;
*** [[DOPA decarboxylase]]&lt;br /&gt;
*** [[Dopamine receptor]]&lt;br /&gt;
*** [[Dronpa]]&lt;br /&gt;
*** [[Dual specificity phosphatase]]&lt;br /&gt;
*** [[Dual specificity protein kinase]]&lt;br /&gt;
*** [[Dynactin]]&lt;br /&gt;
*** [[D-xylose isomerase]]&lt;br /&gt;
*** [[Dynein]]&lt;br /&gt;
** E&lt;br /&gt;
*** [[Ecotin]]&lt;br /&gt;
*** [[Ectonucleoside triphosphate diphosphohydrolase]] (NTPDase)&lt;br /&gt;
*** [[Eglin]]&lt;br /&gt;
*** [[Elastase]]&lt;br /&gt;
*** [[Elongation factor]] (EF)&lt;br /&gt;
*** [[Endonuclease]]&lt;br /&gt;
*** [[Endoplasmin]]&lt;br /&gt;
*** [[Enolase]]&lt;br /&gt;
*** [[Enoyl-Acyl-Carrier Protein Reductase]]&lt;br /&gt;
*** [[Enoyl-CoA hydratase]]&lt;br /&gt;
*** [[Enoylpyruvate transferase]] (MurA)&lt;br /&gt;
*** [[Ephrin]]&lt;br /&gt;
*** [[Ephrin receptor]]&lt;br /&gt;
*** [[Epidermal growth factor]] (EGF)&lt;br /&gt;
*** [[Epidermal_Growth_Factor_Receptor#3D_Structures_of_Epidermal_Growth_Factor_Receptor|Epidermal Growth Factor Receptor]] (EGFR)&lt;br /&gt;
*** [[EPSP synthase]] (5-EnolPyruvylShikimate 3-Phosphate synthase)&lt;br /&gt;
*** [[ER-resident protein]]&lt;br /&gt;
*** [[Erythrocyte binding antigen]]&lt;br /&gt;
*** [[Estrogen receptor]]&lt;br /&gt;
*** [[Estrogen-related receptor]]&lt;br /&gt;
*** [[Ets1]] (E26 transformation-specific)&lt;br /&gt;
*** [[Eukaryotic initiation factor]] (eIF)&lt;br /&gt;
*** [[ExbD]]&lt;br /&gt;
*** [[Exoenzyme]]&lt;br /&gt;
*** [[Exonuclease]]&lt;br /&gt;
*** [[Exotoxin]]&lt;br /&gt;
*** [[Exportin]]&lt;br /&gt;
** F&lt;br /&gt;
*** [[F-actin capping protein]]&lt;br /&gt;
*** [[Factor inhibiting HIF]]&lt;br /&gt;
*** [[Factor VIIa]]&lt;br /&gt;
*** [[Factor VIII]]&lt;br /&gt;
*** [[Factor IX]]&lt;br /&gt;
*** [[Factor Xa]]&lt;br /&gt;
*** [[Factor XIa]]&lt;br /&gt;
*** [[Factor XIII]] &lt;br /&gt;
*** [[Farnesyl diphosphate synthase]]&lt;br /&gt;
*** [[Farnesyltransferase]]&lt;br /&gt;
*** [[Fasciculin]]&lt;br /&gt;
*** [[Fatty acid amide hydrolase]]&lt;br /&gt;
*** [[Fatty acid synthase]]&lt;br /&gt;
*** [[Fatty acid-binding protein]]&lt;br /&gt;
*** [[Ferredoxin#3D_structures_of_ferredoxin|Ferredoxin]]&lt;br /&gt;
*** [[Ferredoxin NADP+ reductase]]&lt;br /&gt;
*** [[Ferredoxin thioredoxin reductase]]&lt;br /&gt;
*** [[Ferric enterobactin receptor]]&lt;br /&gt;
*** [[Ferritin]]&lt;br /&gt;
*** [[Ferrochelatase]]&lt;br /&gt;
*** [[FhuD]]&lt;br /&gt;
*** [[Fibrin]] &lt;br /&gt;
*** [[Fibrinogen]]&lt;br /&gt;
*** [[Fibrinogen binding protein]]&lt;br /&gt;
*** [[Fibritin]]&lt;br /&gt;
*** [[Fibroblast growth factor]] (FGF)&lt;br /&gt;
*** [[Fibroblast growth factor receptor]] (FGFR)&lt;br /&gt;
*** [[Fibronectin]]&lt;br /&gt;
*** [[Ficolin]]&lt;br /&gt;
*** [[Filamin]]&lt;br /&gt;
*** [[FIS protein]]&lt;br /&gt;
*** [[FK506 binding protein]] (FKBP)&lt;br /&gt;
*** [[Flagellar hook of bacteria]]&lt;br /&gt;
*** [[Flavin reductase]]&lt;br /&gt;
*** [[Flavocytochrome]]&lt;br /&gt;
*** [[Flavodoxin]]&lt;br /&gt;
*** [[Focal adhesion kinase]] (FAK)&lt;br /&gt;
*** [[Follicle-stimulating hormone]]&lt;br /&gt;
*** [[Forkhead box protein]] (FOX)&lt;br /&gt;
*** [[Formate dehydrogenase]]&lt;br /&gt;
*** [[Formyl-CoA transferase]]&lt;br /&gt;
*** [[Fructokinase]]&lt;br /&gt;
*** [[Fumarase]]&lt;br /&gt;
&lt;br /&gt;
** G&lt;br /&gt;
*** [[G3p]]&lt;br /&gt;
*** [[Gag polyprotein]]&lt;br /&gt;
*** [[Gal3-Gal80-Gal4]]&lt;br /&gt;
*** [[galactose mutarotase]]&lt;br /&gt;
*** [[Galactose oxidase]]&lt;br /&gt;
*** [[Galactose-binding lectin]]&lt;br /&gt;
*** [[Galactosidase]]&lt;br /&gt;
*** [[Galectin]]&lt;br /&gt;
*** [[Gcn4]]&lt;br /&gt;
*** [[Gelsolin]]&lt;br /&gt;
*** [[Geranylgeranyl pyrophosphate synthase]] (GGPPS)&lt;br /&gt;
*** [[Geranylgeranyl transferase]]&lt;br /&gt;
*** [[Glucagon]]&lt;br /&gt;
*** [[Glucanase]]&lt;br /&gt;
*** [[Glucocorticoid receptor]]&lt;br /&gt;
*** [[Glucokinase Regulatory Protein]]&lt;br /&gt;
*** [[Glucosamine 6-phosphate synthase]]&lt;br /&gt;
*** [[Glucose-1-phosphate thymidylyltransferase]] (RmlA)&lt;br /&gt;
*** [[Glucose-dependent Insulinotropic Polypeptide Receptor]]&lt;br /&gt;
*** [[Glucose-fructose oxidoreductase]]&lt;br /&gt;
*** [[Glutamate dehydrogenase]]&lt;br /&gt;
*** [[Glutamate racemase]]&lt;br /&gt;
*** [[Ionotropic_Glutamate_Receptors#3D_structures_of_glutamate_receptor|Glutamate Receptor]]&lt;br /&gt;
*** [[Glutaminase]]&lt;br /&gt;
*** [[Glutamine Synthase]]&lt;br /&gt;
*** [[Glutaminyl cyclase]]&lt;br /&gt;
*** [[Glutaryl-CoA dehydrogenase]]&lt;br /&gt;
*** [[Glutathione peroxidase]]&lt;br /&gt;
*** [[Glutathione Reductase]]&lt;br /&gt;
*** [[Glutathione S-transferase]]&lt;br /&gt;
*** [[Glutathione synthetase]]&lt;br /&gt;
*** [[Glycerate kinase]]&lt;br /&gt;
*** [[Glycerol kinase]]&lt;br /&gt;
*** [[Glyceraldehyde-3-Phosphate Dehydrogenase]] (GAPDH)&lt;br /&gt;
*** [[Glycerol-3-Phosphate Dehydrogenase]]&lt;br /&gt;
*** [[Glycogen Phosphorylase]]&lt;br /&gt;
*** [[Glycogen synthase kinase 3]] (GSK-3)&lt;br /&gt;
*** [[Glycogenin]]&lt;br /&gt;
*** [[Glycolate oxidase]]&lt;br /&gt;
*** [[Glycoproteins B and D]]&lt;br /&gt;
*** [[Glycosylasparaginase]]&lt;br /&gt;
*** [[Glycosyltransferase]]&lt;br /&gt;
*** [[Glyoxalase]]&lt;br /&gt;
*** [[GMP synthase]]&lt;br /&gt;
*** [[Gp120]]&lt;br /&gt;
*** [[Gp41]]&lt;br /&gt;
*** [[Gramicidin]]&lt;br /&gt;
*** [[Granzyme]]&lt;br /&gt;
*** [[Green Fluorescent Protein]] (GFP)&lt;br /&gt;
*** [[Group I intron]]&lt;br /&gt;
*** [[Growth differentiation factor]] (GDF)&lt;br /&gt;
*** [[Growth factor receptor-bound protein]]&lt;br /&gt;
*** [[GTP-binding protein]]&lt;br /&gt;
*** [[GTPase HRas]]&lt;br /&gt;
*** [[Guanine nucleotide-binding protein]]&lt;br /&gt;
*** [[Guanine nucleotide dissociation inhibitor]] (GDI)&lt;br /&gt;
*** [[Guanylate kinase]]&lt;br /&gt;
*** [[Gyrase]]&lt;br /&gt;
** H &lt;br /&gt;
*** [[Haloperoxidase]]&lt;br /&gt;
*** [[Heat shock factor]]&lt;br /&gt;
*** [[Heat Shock Proteins]]&lt;br /&gt;
*** [[Helicase]]&lt;br /&gt;
*** [[Hemagglutinin]]&lt;br /&gt;
*** [[Hemagglutinin-esterase]]&lt;br /&gt;
*** [[Heme oxygenase]]&lt;br /&gt;
*** [[Hemoglobin]] &lt;br /&gt;
*** [[Hemoglobin 3D structures]]&lt;br /&gt;
*** [[Hemolysin]]&lt;br /&gt;
*** [[Hepatocyte growth factor]] (HGF)&lt;br /&gt;
*** [[Hepatocyte growth factor receptor]] (HGFR)&lt;br /&gt;
*** [[Hexokinase]]&lt;br /&gt;
*** [[HhaI DNA methyltransferase]]&lt;br /&gt;
*** [[Hirudin]]&lt;br /&gt;
*** [[Histidine triad nucleotide-binding protein]] (HINT)&lt;br /&gt;
*** [[Histone]]&lt;br /&gt;
*** [[Histone acetyltransferase]]&lt;br /&gt;
*** [[Histone deacetylase]]&lt;br /&gt;
*** [[Histone methyltransferase]]&lt;br /&gt;
*** [[HIV integrase]]&lt;br /&gt;
*** [[HIV-1 NEF]]&lt;br /&gt;
*** [[HMGR#Additional_3D_Structures_of_HMG-CoA_Reductase|HMG-CoA Reductase]]&lt;br /&gt;
*** [[Homoaconitase]]&lt;br /&gt;
*** [[Homocitrate synthase]]&lt;br /&gt;
*** [[Horseradish peroxidase]]&lt;br /&gt;
*** [[Human growth hormone]] (hGH)&lt;br /&gt;
*** [[Human rhinovirus]]&lt;br /&gt;
*** [[Hyaluronidase]]&lt;br /&gt;
*** [[Hydroxysteroid dehydrogenase]]&lt;br /&gt;
*** [[HypA]]&lt;br /&gt;
*** [[Hypoxia-inducible factor prolyl hydroxylase]]&lt;br /&gt;
** I&lt;br /&gt;
*** [[Importin]]&lt;br /&gt;
*** [[Indole pyruvate decarboxylase]]&lt;br /&gt;
*** [[Indole-3-glycerol phosphate synthase]] (IGPS)&lt;br /&gt;
*** [[Inorganic pyrophosphatase]]&lt;br /&gt;
*** [[Inosine monophosphate dehydrogenase]] (IMPDH)&lt;br /&gt;
*** [[Inositol 1,4,5-Trisphosphate Receptor]]&lt;br /&gt;
*** [[Inositol Monophosphatase]]&lt;br /&gt;
*** [[Insulin]]&lt;br /&gt;
*** [[Insulin-Degrading Enzyme]] (IDE)&lt;br /&gt;
*** [[Insulin-like growth factor]] (IGF)&lt;br /&gt;
*** [[Insulin-like growth factor receptor]] (IGFR)&lt;br /&gt;
*** [[Insulin receptor]]&lt;br /&gt;
*** [[Integrin]]&lt;br /&gt;
*** [[Intercellular adhesion molecule]] (ICAM)&lt;br /&gt;
*** [[Interferon]]&lt;br /&gt;
*** [[Interferon receptor]]&lt;br /&gt;
*** [[Interferon regulatory factor]] (IRF)&lt;br /&gt;
*** [[Interleukin]]&lt;br /&gt;
*** [[Interleukin receptor]]&lt;br /&gt;
*** [[Interleukin-1 receptor antagonist]]&lt;br /&gt;
*** [[Interleukin-1 receptor-associated kinase 4]]&lt;br /&gt;
*** [[Ion_channels#Available_structures|Ion Channels]]&lt;br /&gt;
*** [[Ionotropic Glutamate Receptors]]&lt;br /&gt;
*** [[Ire1]]&lt;br /&gt;
*** [[Isochorismate pyruvate lyase]]&lt;br /&gt;
*** [[Isocitrate dehydrogenase]]&lt;br /&gt;
*** [[Isocitrate dehydrogenase kinase/phosphatase]] (IDHK/P)&lt;br /&gt;
*** [[Isopenicillin N synthase]]&lt;br /&gt;
*** [[Isopentenyl-diphosphate delta-isomerase]]&lt;br /&gt;
*** [[Isopropylmalate dehydrogenase]]&lt;br /&gt;
** J&lt;br /&gt;
*** [[Janus kinase]] (JAK)&lt;br /&gt;
*** [[Jumonji domain-containing protein 2A]] (JMJD2A)&lt;br /&gt;
** K&lt;br /&gt;
*** [[Kallikrein]]&lt;br /&gt;
*** [[Kdo-8-phosphate synthase]]&lt;br /&gt;
*** [[Kelch-like ECH-associated protein 1]] (Keap1)&lt;br /&gt;
*** [[Kemp eliminase]]&lt;br /&gt;
*** [[Keratins]]&lt;br /&gt;
*** [[Ketohexokinase]]&lt;br /&gt;
*** [[Ketosteroid Isomerase]] (KSI)&lt;br /&gt;
*** [[Kinesin]]&lt;br /&gt;
** L&lt;br /&gt;
*** [[L-rhamnose isomerase]]&lt;br /&gt;
*** [[Lac repressor]]&lt;br /&gt;
*** [[Lactalbumin]]&lt;br /&gt;
*** [[Lactate Dehydrogenase]]&lt;br /&gt;
*** [[Lactoferrin]]&lt;br /&gt;
*** [[Lactoperoxidase]]&lt;br /&gt;
*** [[Lactose Permease]]&lt;br /&gt;
*** [[Lambda repressor]]&lt;br /&gt;
*** [[Large T Antigen]]&lt;br /&gt;
*** [[LDL receptor]]&lt;br /&gt;
*** [[LepA]]&lt;br /&gt;
*** [[Leptin]]&lt;br /&gt;
*** [[Leucine transporter]]&lt;br /&gt;
*** [[Leukocyte immunoglobulin-like receptor]]&lt;br /&gt;
*** [[Leukotriene A4 Hydrolase]]&lt;br /&gt;
*** [[Leukotriene B4 hydroxydehydrogenase]]&lt;br /&gt;
*** [[Leukotriene C4 synthase]]&lt;br /&gt;
*** [[Lignin peroxidase]]&lt;br /&gt;
*** [[Lipase]]&lt;br /&gt;
*** [[Luciferase]]&lt;br /&gt;
*** [[Lysine-specific histone demethylase 1]] (LSD1)&lt;br /&gt;
*** [[Lysozyme]]&lt;br /&gt;
*** [[Lysozyme 3D structures]]&lt;br /&gt;
** M&lt;br /&gt;
*** [[M2 protein]]&lt;br /&gt;
*** [[Macrophage inhibitory factor]] (MIF)&lt;br /&gt;
*** [[Major histocompatibility complex]] (MHC)&lt;br /&gt;
*** [[Malate dehydrogenase]] (MDH)&lt;br /&gt;
*** [[Malate synthase]]&lt;br /&gt;
*** [[Maltose-binding protein]] (MBP)&lt;br /&gt;
*** [[Mandelate dehydrogenase]]&lt;br /&gt;
*** [[Mandelate racemase]]&lt;br /&gt;
*** [[Manganese peroxidase]]&lt;br /&gt;
*** [[Mannose-binding protein]]&lt;br /&gt;
*** [[Mannosidase]]&lt;br /&gt;
*** [[Matriptase]]&lt;br /&gt;
*** [[Matrix metalloproteinase]]&lt;br /&gt;
*** [[MDM2]]&lt;br /&gt;
*** [[MDM4]]&lt;br /&gt;
*** [[MECDP synthase]]&lt;br /&gt;
*** [[Mediator]]&lt;br /&gt;
*** [[Menin]]&lt;br /&gt;
*** [[MEP cytidylyltransferase]] (IspD)&lt;br /&gt;
*** [[Met repressor]]&lt;br /&gt;
*** [[Metabotropic glutamate receptor]]&lt;br /&gt;
*** [[Methane monooxygenase]]&lt;br /&gt;
*** [[Methanol dehydrogenase]]&lt;br /&gt;
*** [[Methyl CpG binding protein]]&lt;br /&gt;
*** [[Methylamine dehydrogenase]]&lt;br /&gt;
*** [[Methylcitrate synthase]]&lt;br /&gt;
*** [[Methylesterase]]&lt;br /&gt;
*** [[Mitogen-activated protein kinase|Mitogen-activated protein kinase (MAPK)]]&lt;br /&gt;
*** [[Mitogen-activated protein kinase kinase|Mitogen-activated protein kinase kinase (MAP2K)]]&lt;br /&gt;
*** [[Mitogen-activated protein kinase kinase kinase|Mitogen-activated protein kinase kinase kinase (MAP3K)]]&lt;br /&gt;
*** [[ModG]]&lt;br /&gt;
*** [[Monoamine oxidase]]&lt;br /&gt;
*** [[Monoclonal Antibody]]&lt;br /&gt;
*** [[Monooxygenase]]&lt;br /&gt;
*** [[Muconate cycloisomerase]]&lt;br /&gt;
*** [[MurD ligase]]&lt;br /&gt;
*** [[Muscle LIM protein]]&lt;br /&gt;
*** [[Myeloperoxidase]]&lt;br /&gt;
*** [[Myoglobin]]&lt;br /&gt;
*** [[Myosin]]&lt;br /&gt;
*** [[Myosin light chain kinase]]&lt;br /&gt;
*** [[Myotilin]]&lt;br /&gt;
** N&lt;br /&gt;
*** [[NAC transcription factor]]&lt;br /&gt;
*** [[NAD synthase]]&lt;br /&gt;
*** [[NAD(P) transhydrogenase]]&lt;br /&gt;
*** [[NADH peroxidase]]&lt;br /&gt;
*** [[NADPH-Cytochrome P450 Reductase]] &lt;br /&gt;
*** [[NADPH dehydrogenase]] (OYE)&lt;br /&gt;
*** [[Nawaprin]]&lt;br /&gt;
*** [[Nebulin]]&lt;br /&gt;
*** [[NEDD8]]&lt;br /&gt;
*** [[Neprilysin]]&lt;br /&gt;
*** [[Neuraminidase]]&lt;br /&gt;
*** [[Neurexin]]&lt;br /&gt;
*** [[Neuroglobin]]&lt;br /&gt;
*** [[Neuroligin]]&lt;br /&gt;
*** [[Neuropilin]]&lt;br /&gt;
*** [[Neutrophil gelatinase-associated lipocalin]]&lt;br /&gt;
*** [[NF-kB]]&lt;br /&gt;
*** [[Nitrate reductase]]&lt;br /&gt;
*** [[Nitric Oxide Synthase]] &lt;br /&gt;
*** [[Nitric reductase]]&lt;br /&gt;
*** [[Nitrile hydratase]]&lt;br /&gt;
*** [[Nitrogenase]]&lt;br /&gt;
*** [[Nitroreductase]]&lt;br /&gt;
*** [[NK cell receptor]]&lt;br /&gt;
*** [[NodS]]&lt;br /&gt;
*** [[Nonstructural protein]]&lt;br /&gt;
*** [[Nuclear receptor coactivator]]&lt;br /&gt;
*** [[Nucleoplasmin]]&lt;br /&gt;
*** [[Nucleoporin]]&lt;br /&gt;
*** [[Nucleoprotein]]&lt;br /&gt;
*** [[Nucleoside diphosphate kinase]]&lt;br /&gt;
** O&lt;br /&gt;
*** [[Obscurin]]&lt;br /&gt;
*** [[O-GlcNAc transferase]]&lt;br /&gt;
*** [[Odorant binding protein]]&lt;br /&gt;
*** [[Oligopeptide-binding protein]]&lt;br /&gt;
*** [[Opioid receptor]]&lt;br /&gt;
*** [[Organic hydroperoxide resistance protein]]&lt;br /&gt;
*** [[Ornithine carbamoyltransferase]]&lt;br /&gt;
*** [[Ornithine decarboxylase]]&lt;br /&gt;
*** [[Outer surface protein]]&lt;br /&gt;
*** [[Ovalbumin]]&lt;br /&gt;
** P&lt;br /&gt;
*** [[P19]]&lt;br /&gt;
*** [[P53]]&lt;br /&gt;
*** [[P73]]&lt;br /&gt;
*** [[P-hydroxybenzoate hydroxylase]]&lt;br /&gt;
*** [[Paired box protein]] (PAX)&lt;br /&gt;
*** [[Pal]]&lt;br /&gt;
*** [[Pantothenate kinase]]&lt;br /&gt;
*** [[Pantothenate synthetase]]&lt;br /&gt;
*** [[Papain]]&lt;br /&gt;
*** [[Parvalbumin]]&lt;br /&gt;
*** [[PCSK9]]&lt;br /&gt;
*** [[PDZ and LIM domain protein]]&lt;br /&gt;
*** [[Penicillin acylase]]&lt;br /&gt;
*** [[Penicillin-binding protein]]&lt;br /&gt;
*** [[Penicillopepsin]]&lt;br /&gt;
*** [[Pentaerythritol tetranitrate reductase]]&lt;br /&gt;
*** [[Pepsin]]&lt;br /&gt;
*** [[Peptidase T]]&lt;br /&gt;
*** [[Peptidyl-tRNA hydrolase]] (PTH)&lt;br /&gt;
*** [[Peroxiredoxin]]&lt;br /&gt;
*** [[Pertussis toxin]]&lt;br /&gt;
*** [[PPAR#Additional_3D_Structures_of_PPAR|Peroxisome Proliferator-Activated Receptors (PPAR)]]&lt;br /&gt;
*** [[Phage integrase]]&lt;br /&gt;
*** [[Phenylalanine hydroxylase]]&lt;br /&gt;
*** [[Phenylethanolamine N-methyltransferase]] (PNMT)&lt;br /&gt;
*** [[Phenylpyruvate decarboxylase]]&lt;br /&gt;
*** [[PhoP-PhoQ]]&lt;br /&gt;
*** [[Phosphate-binding protein]]&lt;br /&gt;
*** [[Phosphatidylinositol-specific phospholipase C]] (PIPLC)&lt;br /&gt;
*** [[Phosphocarrier protein HPr]]&lt;br /&gt;
*** [[Phosphodiesterase]]&lt;br /&gt;
*** [[Phosphoenolpyruvate carboxykinase]] (PEPCK)&lt;br /&gt;
*** [[Phosphoenolpyruvate carboxylase]] (PEPC)&lt;br /&gt;
*** [[Phosphofructokinase (PFK)]]&lt;br /&gt;
*** [[Phosphoglucose isomerase]] (PGI)&lt;br /&gt;
*** [[Phosphoglycerate dehydrogenase]]&lt;br /&gt;
*** [[Phosphoglycerate Kinase]]&lt;br /&gt;
*** [[Phosphoglycerate Mutase]]&lt;br /&gt;
*** [[Phosphoinositide_3-Kinase#Additional_3D_Structures|Phosphoinositide 3-Kinase]] (PI3K)&lt;br /&gt;
*** [[Phospholipase A2|Phospholipase A2 (PLA2)]]&lt;br /&gt;
*** [[Phosphomannomutase]]&lt;br /&gt;
*** [[Phosphoribosylaminoimidazole carboxylase]] (PurE)&lt;br /&gt;
*** [[Phosphoribosyltransferase]]&lt;br /&gt;
*** [[Phosphoserine aminotransferase]]&lt;br /&gt;
*** [[Phosphoserine phosphatase]]&lt;br /&gt;
*** [[Phosphotransferase]]&lt;br /&gt;
*** [[Phosphotriesterase]]&lt;br /&gt;
*** [[Photosystem I]]&lt;br /&gt;
*** [[Photosystem II]]&lt;br /&gt;
*** [[Phycocyanobilin:ferredoxin oxidoreductase]]&lt;br /&gt;
*** [[Pilin]]&lt;br /&gt;
*** [[Plasmepsin]]&lt;br /&gt;
*** [[Plasminogen]]&lt;br /&gt;
*** [[Plasminogen activator]]&lt;br /&gt;
*** [[Plasminogen activator inhibitor]]&lt;br /&gt;
*** [[Platelet-activating factor acetylhydrolase]]&lt;br /&gt;
*** [[Platelet-receptor glycoprotein Ib alpha]] (CD42)&lt;br /&gt;
*** [[Plectin]]&lt;br /&gt;
*** [[Plexin]]&lt;br /&gt;
*** [[Poly(A) Polymerase]]&lt;br /&gt;
*** [[Poly (ADP-ribose) glycohydrolase]] (PARG)&lt;br /&gt;
*** [[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase (PARP)]]&lt;br /&gt;
*** [[Polyamine oxidase]]&lt;br /&gt;
*** [[Polyneuridine Aldehyde Esterase]]&lt;br /&gt;
*** [[Porin]] (Omp)&lt;br /&gt;
*** [[Porphobilinogen Deaminase]]&lt;br /&gt;
*** [[Porphobilinogen synthase]]&lt;br /&gt;
*** [[Potassium_Channel#Additional_Structures_of_Potassium_Channels|Potassium Channel]]&lt;br /&gt;
*** [[Potassium channel toxin]]&lt;br /&gt;
*** [[Pre-mRNA-splicing factor]] (Prp)&lt;br /&gt;
*** [[Pregnane X receptor]] (PXR)&lt;br /&gt;
*** [[Preprotein translocase]]&lt;br /&gt;
*** [[Prion]]&lt;br /&gt;
*** [[Proliferating Cell Nuclear Antigen|Proliferating Cell Nuclear Antigen (PCNA)]]&lt;br /&gt;
*** [[Prolyl Endopeptidase]]&lt;br /&gt;
*** [[Prolyl hydroxylase domain]]&lt;br /&gt;
*** [[Prostaglandin D synthase]] (PGDS)&lt;br /&gt;
*** [[Prostaglandin F synthase]] (AKR1C3)&lt;br /&gt;
*** [[Proteasome]]&lt;br /&gt;
*** [[Protegrin]]&lt;br /&gt;
*** [[Protein disulfide oxidoreductase]]&lt;br /&gt;
*** [[Protein kinase C]]&lt;br /&gt;
*** [[Protein kinase Spk1]] (Rad53)&lt;br /&gt;
*** [[Protein phosphatase]]&lt;br /&gt;
*** [[Proteinase]]&lt;br /&gt;
*** [[Proto-oncogene serine/threonine-protein kinase]] (Pim-1)&lt;br /&gt;
*** [[Proto-oncogene tyrosine-protein kinase]]&lt;br /&gt;
*** [[Pseudechetoxin]]&lt;br /&gt;
*** [[Pseudoazurin]]&lt;br /&gt;
*** [[Pseudopilin]]&lt;br /&gt;
*** [[Pteridine reductase]]&lt;br /&gt;
*** [[Purine nucleoside phosphorylase]] (PNP)&lt;br /&gt;
*** [[Purine repressor]] (PurR)&lt;br /&gt;
*** [[Pyridoxal kinase]]&lt;br /&gt;
*** [[Pyridoxine 5&#039;-phosphate oxidase]]&lt;br /&gt;
*** [[Pyrin domain]]&lt;br /&gt;
*** [[Pyrroline-5-carboxylate dehydrogenase]]&lt;br /&gt;
*** [[Pyrroline-5-carboxylate reductase]]&lt;br /&gt;
*** [[Pyrrolysyl-tRNA synthetase]]&lt;br /&gt;
*** [[Pyruvate-ferredoxin oxidoreductase]]&lt;br /&gt;
*** [[Pyruvate decarboxylase]]&lt;br /&gt;
*** [[Pyruvate dehydrogenase]]&lt;br /&gt;
*** [[Pyruvate dehydrogenase kinase]]&lt;br /&gt;
*** [[Pyruvate Kinase]]&lt;br /&gt;
*** [[Pyruvate phosphate dikinase]]&lt;br /&gt;
** Q&lt;br /&gt;
*** [[Quinone reductase]]&lt;br /&gt;
** R&lt;br /&gt;
*** [[Ras GTPase activating protein]]&lt;br /&gt;
*** [[Recombinase A]] (RecA)&lt;br /&gt;
*** [[Recoverin]]&lt;br /&gt;
*** [[Renin]]&lt;br /&gt;
*** [[Replication Termination Protein]]&lt;br /&gt;
*** [[Resolvase]]&lt;br /&gt;
*** [[Response regulator]]&lt;br /&gt;
*** [[Retinoblastoma protein]]&lt;br /&gt;
*** [[Retinoblastoma-binding protein]]&lt;br /&gt;
*** [[Retinoic acid receptor]]&lt;br /&gt;
*** [[Retinoid X receptor]] (RXR)&lt;br /&gt;
*** [[Retinol-binding protein]]&lt;br /&gt;
*** [[Retroviral Integrase]]&lt;br /&gt;
*** [[Reverse_Transcriptase#3D_Structures_of_Reverse_transcriptase|Reverse Transcriptase]]&lt;br /&gt;
*** [[Rhodopsin]]&lt;br /&gt;
*** [[Rhomboid protease]]&lt;br /&gt;
*** [[Ribonuclease]] (RNase)&lt;br /&gt;
*** [[Ribonuclease inhibitor]]&lt;br /&gt;
*** [[Ribonucleotide reductase]]&lt;br /&gt;
*** [[Ribose-binding protein]]&lt;br /&gt;
*** [[Ribose-5-phosphate isomerase]]&lt;br /&gt;
*** [[Ribosomal protein L11 methyltransferase]]&lt;br /&gt;
*** [[Ribosomal protein S6 kinase]]&lt;br /&gt;
*** Ribosome &amp;amp; Ribosomal Proteins&lt;br /&gt;
**** [[Ribosome#Additional_Ribosome_Structures|Ribosome]]&lt;br /&gt;
**** [[Ribosomal protein L1]]&lt;br /&gt;
**** [[Ribosomal protein L2]]&lt;br /&gt;
**** [[Ribosomal protein L3]]&lt;br /&gt;
**** [[Ribosomal protein L4]]&lt;br /&gt;
**** [[Ribosomal protein L5]]&lt;br /&gt;
**** [[Ribosomal protein L6]]&lt;br /&gt;
**** [[Ribosomal protein L7]]&lt;br /&gt;
**** [[Ribosomal protein L8]]&lt;br /&gt;
**** [[Ribosomal protein L9]]&lt;br /&gt;
**** [[Ribosomal protein L10]]&lt;br /&gt;
**** [[Ribosomal protein L11]]&lt;br /&gt;
**** [[Ribosomal protein L13]]&lt;br /&gt;
**** [[Ribosomal protein L14]]&lt;br /&gt;
**** [[Ribosomal protein L15]]&lt;br /&gt;
**** [[Ribosomal protein L16]]&lt;br /&gt;
**** [[Ribosomal protein L17]]&lt;br /&gt;
**** [[Ribosomal protein L18]]&lt;br /&gt;
**** [[Ribosomal protein L19]]&lt;br /&gt;
**** [[Ribosomal protein L20]]&lt;br /&gt;
**** [[Ribosomal protein L21]]&lt;br /&gt;
**** [[Ribosomal protein L22]]&lt;br /&gt;
**** [[Ribosomal protein L23]]&lt;br /&gt;
**** [[Ribosomal protein L24]]&lt;br /&gt;
**** [[Ribosomal protein L25]]&lt;br /&gt;
**** [[Ribosomal protein L26]]&lt;br /&gt;
**** [[Ribosomal protein L27]]&lt;br /&gt;
**** [[Ribosomal protein L28]]&lt;br /&gt;
**** [[Ribosomal protein L29]]&lt;br /&gt;
**** [[Ribosomal protein L30]]&lt;br /&gt;
**** [[Ribosomal protein L31]]&lt;br /&gt;
**** [[Ribosomal protein L32]]&lt;br /&gt;
**** [[Ribosomal protein L33]]&lt;br /&gt;
**** [[Ribosomal protein L34]]&lt;br /&gt;
**** [[Ribosomal protein L35]]&lt;br /&gt;
**** [[Ribosomal protein L36]]&lt;br /&gt;
**** [[Ribosomal protein L37]]&lt;br /&gt;
**** [[Ribosomal protein L38]]&lt;br /&gt;
**** [[Ribosomal protein L39]]&lt;br /&gt;
**** [[Ribosomal protein L40]]&lt;br /&gt;
**** [[Ribosomal protein L41]]&lt;br /&gt;
**** [[Ribosomal protein L42]]&lt;br /&gt;
**** [[Ribosomal protein L43]]&lt;br /&gt;
**** [[Ribosomal protein L44]]&lt;br /&gt;
**** [[Ribosomal protein P0]]&lt;br /&gt;
**** [[Ribosomal protein P1]]&lt;br /&gt;
**** [[Ribosomal protein P2]]&lt;br /&gt;
**** [[Ribosomal protein S1|Ribosomal protein S1 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S2|Ribosomal protein S2 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S3|Ribosomal protein S3 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S4|Ribosomal protein S4 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S5|Ribosomal protein S5 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S6|Ribosomal protein S6 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S7|Ribosomal protein S7 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S8|Ribosomal protein S8 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S9|Ribosomal protein S9 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S10|Ribosomal protein S10 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S11|Ribosomal protein S11 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S12|Ribosomal protein S12 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S13|Ribosomal protein S13 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S14|Ribosomal protein S14 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S15|Ribosomal protein S15 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S16|Ribosomal protein S16 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S17|Ribosomal protein S17 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S18|Ribosomal protein S18 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S19|Ribosomal protein S19 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S20|Ribosomal protein S20 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S21|Ribosomal protein S21 (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein THX|Ribosomal protein THX (bacterial)]]&lt;br /&gt;
**** [[Ribosomal protein S22|Ribosomal protein S22 (eukaryotes/archaea)]]&lt;br /&gt;
**** [[Ribosomal protein S23|Ribosomal protein S23 (eukaryotes/archaea)]]&lt;br /&gt;
**** [[Ribosomal protein S24|Ribosomal protein S24 (eukaryotes/archaea)]]&lt;br /&gt;
**** [[Ribosomal protein S27|Ribosomal protein S27 (eukaryotes/archaea)]]&lt;br /&gt;
**** [[Ribosomal protein S28|Ribosomal protein S28 (eukaryotes/archaea)]]&lt;br /&gt;
**** [[Ribosomal protein S29|Ribosomal protein S29 (eukaryotes/archaea)]]&lt;br /&gt;
*** [[Riboswitch]]&lt;br /&gt;
*** [[Ribozyme]]&lt;br /&gt;
*** [[Ricin]]&lt;br /&gt;
*** [[RmlC]]&lt;br /&gt;
*** [[RNA ligase]]&lt;br /&gt;
*** [[RNA polymerase]]&lt;br /&gt;
*** [[RNA silencing suppressor]]&lt;br /&gt;
*** [[RNA uridylyltransferase]]&lt;br /&gt;
*** [[Rop protein]]&lt;br /&gt;
*** [[Rossmann fold]]&lt;br /&gt;
*** [[RuBisCO]]&lt;br /&gt;
** S&lt;br /&gt;
*** [[S100 protein]]&lt;br /&gt;
*** [[S-adenosylhomocysteine hydrolase]]&lt;br /&gt;
*** [[SAGA-associated factor]]&lt;br /&gt;
*** [[SAM decarboxylase]]&lt;br /&gt;
*** [[SAM synthetase]]&lt;br /&gt;
*** [[SAM-dependent methyltransferase]]&lt;br /&gt;
*** [[Saposin]]&lt;br /&gt;
*** [[Sarcosine oxidase]]&lt;br /&gt;
*** [[SARS Coronavirus Main Proteinase]]&lt;br /&gt;
*** [[SecA]]&lt;br /&gt;
*** [[Selectin]]&lt;br /&gt;
*** [[Selenocysteine synthase]]&lt;br /&gt;
*** [[Semaphorin]]&lt;br /&gt;
*** [[Sentrin-specific protease]]&lt;br /&gt;
*** [[Sequestosome]]&lt;br /&gt;
*** [[Serine hydroxymethyltransferase]]&lt;br /&gt;
*** [[Serine palmitoyltransferase]]&lt;br /&gt;
*** [[Serine/threonine protein kinase]]&lt;br /&gt;
*** [[Serine/threonine protein phosphatase]]&lt;br /&gt;
*** [[Serotonin N-acetyltransferase]]&lt;br /&gt;
*** [[Serpin]]&lt;br /&gt;
*** [[Serum Paraoxonase]]&lt;br /&gt;
*** [[Severin]]&lt;br /&gt;
*** [[Shank protein]]&lt;br /&gt;
*** [[Shiga toxin]]&lt;br /&gt;
*** [[Shikimate dehydrogenase]]&lt;br /&gt;
*** [[Shikimate kinase]]&lt;br /&gt;
*** [[Shwachman-Bodian-Diamond Syndrome Protein]]&lt;br /&gt;
*** [[Sigma factor]]&lt;br /&gt;
*** [[Signal recognition particle protein]]&lt;br /&gt;
*** [[Signal recognition particle receptor]]&lt;br /&gt;
*** [[Simvastatin Synthase]]&lt;br /&gt;
*** [[Single-stranded DNA-binding protein]]&lt;br /&gt;
*** [[Sm-like protein]]&lt;br /&gt;
*** [[Sorting nexin]]&lt;br /&gt;
*** [[Spectrin]]&lt;br /&gt;
*** [[Spermidine Synthase]]&lt;br /&gt;
*** [[Spermidine/spermine N-acetyltransferase]]&lt;br /&gt;
*** [[Sphingomyelinase]]&lt;br /&gt;
*** [[Squalene synthase]]&lt;br /&gt;
*** [[Squalene-hopene cyclase]]&lt;br /&gt;
*** [[Staphylococcal nuclease]]&lt;br /&gt;
*** [[Stimulator of interferon genes]] (STING)&lt;br /&gt;
*** [[Strictosidine Synthase]]&lt;br /&gt;
*** [[Subtilisin]]&lt;br /&gt;
*** [[Succinate Dehydrogenase]]&lt;br /&gt;
*** [[Succinate-semialdehyde dehydrogenase]]&lt;br /&gt;
*** [[Succinyl-CoA synthetase]]&lt;br /&gt;
*** [[Sulfhydryl oxidase]]&lt;br /&gt;
*** [[Sulfite Oxidase]]&lt;br /&gt;
*** [[Sulfotransferase]]&lt;br /&gt;
*** [[Sulfurtransferase]]&lt;br /&gt;
*** [[SUMO]]&lt;br /&gt;
*** [[SUMO conjugating enzyme Ubc9]]&lt;br /&gt;
*** [[Superoxide Dismutase]]&lt;br /&gt;
*** [[Superoxide Reductase]] &lt;br /&gt;
*** [[Survivin]]&lt;br /&gt;
** T&lt;br /&gt;
*** [[TAL effector]]&lt;br /&gt;
*** [[Talin]]&lt;br /&gt;
*** [[Tat protein]]&lt;br /&gt;
*** [[TATA-Binding Protein]] (TBP)&lt;br /&gt;
*** [[T-box proteins]] (TBX)&lt;br /&gt;
*** [[T-cell receptor]] (TCR)&lt;br /&gt;
*** [[Telethonin]] &lt;br /&gt;
*** [[Telomerase]]&lt;br /&gt;
*** [[TEM1-beta-Lactamase/beta-lactamase Inhibitor Protein (BLIP)]]&lt;br /&gt;
*** [[Tetanus toxin]]&lt;br /&gt;
*** [[Tetherin]]&lt;br /&gt;
*** [[Tetracycline repressor protein]] (TetR)&lt;br /&gt;
*** [[Thermolysin]]&lt;br /&gt;
*** [[Thioesterase]]&lt;br /&gt;
*** [[Thiol peroxidase]]&lt;br /&gt;
*** [[Thiolase]]&lt;br /&gt;
*** [[Thioredoxin]]&lt;br /&gt;
*** [[Thioredoxin Glutathion Reductase]]&lt;br /&gt;
*** [[Thioredoxin Reductase]]&lt;br /&gt;
*** [[Thrombin]]&lt;br /&gt;
*** [[Thymidine kinase]]&lt;br /&gt;
*** [[Thymidylate kinase]]&lt;br /&gt;
*** [[Thymidylate synthase]]&lt;br /&gt;
*** [[Tissue factor]] (TF)&lt;br /&gt;
*** [[Titin]]&lt;br /&gt;
*** [[Tobacco Etch Virus (TEV) Protease]]&lt;br /&gt;
*** [[Tobacco Mosaic Virus]] (TMV)&lt;br /&gt;
*** [[TolA]]&lt;br /&gt;
*** [[TolB]]&lt;br /&gt;
*** [[Toll-like receptor]]&lt;br /&gt;
*** [[TolR]]&lt;br /&gt;
*** [[TonB]]&lt;br /&gt;
*** [[Topoisomerase]]&lt;br /&gt;
*** [[Topoisomerase binding protein]]&lt;br /&gt;
*** [[TRAIL]]&lt;br /&gt;
*** [[Transaldolase]]&lt;br /&gt;
*** [[Transcription factor SIII]]&lt;br /&gt;
*** [[Transcription initiation factor]] (TFII)&lt;br /&gt;
*** [[Transcription-repair coupling factor|Transcription-repair coupling factor (TRCF)]] &lt;br /&gt;
*** [[Transcriptional activator]]&lt;br /&gt;
*** [[Transducin]]&lt;br /&gt;
*** [[Transferrin]]&lt;br /&gt;
*** [[Transferrin receptor]]&lt;br /&gt;
*** [[Transketolase]]&lt;br /&gt;
*** [[Transport inhibitor response 1]]&lt;br /&gt;
*** [[Transposase]]&lt;br /&gt;
*** [[Transthyretin]]&lt;br /&gt;
*** [[Trehalulose synthase]]&lt;br /&gt;
*** [[Trichodiene synthase]]&lt;br /&gt;
*** [[Triose Phosphate Isomerase]] (TIM)&lt;br /&gt;
*** [[Tripeptidyl peptidase]]&lt;br /&gt;
*** [[tRNA methyltransferase]] (Trm)&lt;br /&gt;
*** [[tRNA pseudouridine synthase]]&lt;br /&gt;
*** [[tRNA-guanine transglycosylase]] (TGT)&lt;br /&gt;
*** [[Tropomyosin]]&lt;br /&gt;
*** [[Troponin]]&lt;br /&gt;
*** [[Trypanothione reductase]]&lt;br /&gt;
*** [[Trypsin]]&lt;br /&gt;
*** [[Trypsin inhibitor]]&lt;br /&gt;
*** [[Tryptase]]&lt;br /&gt;
*** [[Tryptase inhibitor]]&lt;br /&gt;
*** [[Tryptophan hydroxylase]]&lt;br /&gt;
*** [[Tryptophan RNA-binding attenuation protein]] (TRAP)&lt;br /&gt;
*** [[Tryptophan synthase]]&lt;br /&gt;
*** [[Tubulin]]&lt;br /&gt;
*** [[Tumor necrosis factor]] (TNF)&lt;br /&gt;
*** [[Tumor necrosis factor receptor]] (TNFR; TNFRSF)&lt;br /&gt;
*** [[Tyrosine hydroxylase]]&lt;br /&gt;
*** [[Tyrosine kinase]]&lt;br /&gt;
*** [[Tyrosine phosphatase]]&lt;br /&gt;
** U&lt;br /&gt;
*** [[U5-15kD]]&lt;br /&gt;
*** [[Ubiquitin]]&lt;br /&gt;
*** [[Ubiquitin activating enzyme]]&lt;br /&gt;
*** [[Ubiquitin conjugating enzyme]]&lt;br /&gt;
*** [[Ubiquitin protein ligase]]&lt;br /&gt;
*** [[UDP-3-O-acyl-N-acetylglucosamine deacetylase]] (LpxC)&lt;br /&gt;
*** [[UDP-galactopyranose mutase]]&lt;br /&gt;
*** [[UDP-galactose 4-epimerase]]&lt;br /&gt;
*** [[Undecaprenyl pyrophosphate synthase]]&lt;br /&gt;
*** [[Uracil glycosylate inhibitor]]&lt;br /&gt;
*** [[Uracil-DNA glycosylase]] (UDG)&lt;br /&gt;
*** [[Uracil-DNA glycosylase inhibitor]] (UDI)&lt;br /&gt;
*** [[Urate Oxidase]]&lt;br /&gt;
*** [[Urea transporter]]&lt;br /&gt;
*** [[Urease]]&lt;br /&gt;
*** [[Urease accessory protein]]&lt;br /&gt;
*** [[Uridine 5&#039;-monophosphate synthase]]&lt;br /&gt;
*** [[Uridine phosphorylase]]&lt;br /&gt;
*** [[Uridylate kinase]]&lt;br /&gt;
*** [[Urokinase]]&lt;br /&gt;
*** [[UvrABC]]&lt;br /&gt;
** V&lt;br /&gt;
*** [[Vanillyl-alcohol oxidase]]&lt;br /&gt;
*** [[Variable lymphocyte receptor]]&lt;br /&gt;
*** [[Vasodilator-stimulated phosphoprotein]]&lt;br /&gt;
*** [[VEGF#Additional_3D_Structures_of_VEGF|Vascular Endothelial Growth Factor]] (VEGF)&lt;br /&gt;
*** [[VEGFR#Additional_3D_Structures_of_VEGFR|Vascular Endothelial Growth Factor Receptor]] (VEGFR)&lt;br /&gt;
*** [[Villin]]&lt;br /&gt;
*** [[Vinculin]]&lt;br /&gt;
*** [[VirE1-VirE2]]&lt;br /&gt;
*** [[Virus coat protein]]&lt;br /&gt;
*** [[Virus protease]]&lt;br /&gt;
*** [[Vitamin D receptor]]&lt;br /&gt;
** W &lt;br /&gt;
** X&lt;br /&gt;
*** [[Xanthine dehydrogenase]]&lt;br /&gt;
*** [[Xylosidase]]&lt;br /&gt;
** Y&lt;br /&gt;
*** [[YbgF]]&lt;br /&gt;
** Z&lt;br /&gt;
*** [[Z-DNA]]&lt;br /&gt;
*** [[ZASP protein]]&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049335</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049335"/>
		<updated>2014-11-02T17:23:43Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Keratins&amp;diff=2049334</id>
		<title>Keratins</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Keratins&amp;diff=2049334"/>
		<updated>2014-11-02T17:19:05Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Hydrophobic residues: Main points of contact between chains */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Note: This entry on keratins has been published in Biochem. Mol. Biol. Educ.&amp;lt;ref&amp;gt;PMID:24265184&amp;lt;/ref&amp;gt;. Please cite it as Biochem. Mol. Biol. Educ. 42:93-4, 2014.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Keratin&#039;&#039;&#039; is the name given to a large family of homologous proteins that have a filamentous (fibrous) structure. These proteins are expressed in epithelial cells and in epidermal cells where they are assembled forming cytoskeletal structures within the cell and epidermal derivatives such as hair, nail and horn &amp;lt;ref&amp;gt;PMID:18461349&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The keratins represent the largest branch within the super-family of intermediate-filament (IF) proteins &amp;lt;ref name=&amp;quot;Godsel-2008&amp;quot;&amp;gt;PMID:18083519&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;PMID:19587451&amp;lt;/ref&amp;gt;. Keratins are grouped into two families termed as type I and type II keratins based on their sequence homology &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot;&amp;gt;PMID:6191871&amp;lt;/ref&amp;gt;. Similarly, other IF proteins are also grouped into families termed consecutively as types III, IV, V and VI IF proteins, based on their sequence homology &amp;lt;ref&amp;gt;PMID:8982454&amp;lt;/ref&amp;gt;. These families include desmin, vimentin, neurofilament protein and GFAP that are expressed in specific tissues and cell types &amp;lt;ref name=&amp;quot;Godsel-2008&amp;quot; /&amp;gt;. The IF family of lamins are located on the nuclear lamina and are ubiquitously expressed &amp;lt;ref name=&amp;quot;Godsel-2008&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==Intermediate filaments==&lt;br /&gt;
&lt;br /&gt;
In most eukaryotic cells there are three major cytoskeletal systems: &amp;lt;ref&amp;gt;PMID:22584905&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
* Microfilaments composed of [[actin]] subunits &lt;br /&gt;
* Intermediate filaments&lt;br /&gt;
* Microtubules composed of [[tubulin]] subunits&lt;br /&gt;
&lt;br /&gt;
The name &amp;quot;intermediate filament&amp;quot; reflects the comparative morphology of these filaments as their diameter is about 8-12 nm; a value that is &amp;quot;intermediate&amp;quot; between microfilaments with a diameter of 6-7 nm and microtubules with a diameter of 25 nm &amp;lt;ref&amp;gt;PMID:19565362&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Both microfilaments and microtubules are assembled from globular subunits of actin and tubulin respectively. In contrast, intermediate filaments (IFs) are composed of proteins that have a long fibrous structure that results from long stretches of alpha helical domains.&lt;br /&gt;
&lt;br /&gt;
The basic building block of each intermediate filament is a dimer of a coiled-coil pair of IF proteins. Each keratin filament is assembled as a hetero-dimer of a type I keratin coiled together with a type II keratin. &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot;&amp;gt;PMID:6191871&amp;lt;/ref&amp;gt;. Other types of IFs are mostly composed of homo-dimers &amp;lt;ref name=&amp;quot;Godsel-2008&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==Primary structures of keratins==&lt;br /&gt;
&lt;br /&gt;
In humans there are 54 functional genes that code for keratins &amp;lt;ref&amp;gt;PMID:16831889&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Hesse-2004&amp;quot;&amp;gt;PMID:15085952&amp;lt;/ref&amp;gt;. The first sequences of human keratin cDNAs revealed that there are two distinct but homologous keratin families &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot; /&amp;gt; &amp;lt;ref name=&amp;quot;Hanukoglu-1982&amp;quot;&amp;gt;PMID:6186381&amp;lt;/ref&amp;gt;. These two distinct types were named as Type I keratin and Type II keratin &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Human genome sequencing revealed that type I and type II keratin genes are located in two clusters each of which includes 27 genes on chromosome 17q21 and on chromosome 12q13 respectively &amp;lt;ref name=&amp;quot;Hesse-2004&amp;quot; /&amp;gt; &amp;lt;ref&amp;gt;PMID:17428470&amp;lt;/ref&amp;gt;. The juxtaposed location of the genes indicate that these gene clusters evolved by a series of gene duplication events.&lt;br /&gt;
&lt;br /&gt;
Determination of the sequences of type I and type keratins revealed that the two types of keratins have a central ~310 residue long segment that share ~30% homology, but the amino and carboxy terminal regions of these proteins show great diversity &amp;lt;ref name=&amp;quot;Hanukoglu-1982&amp;quot; /&amp;gt;. Consistent with the initial observations, sequencing of keratins and other intermediate filament proteins showed that all IF proteins have a conserved central domain and widely divergent amino and carboxy terminal regions &amp;lt;ref&amp;gt;PMID: 17521629&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Sequencing and two dimensional gel electrophoresis of the complete family of keratins revealed that the type I and type II keratins differ in their size and isoelectric points &amp;lt;ref name=&amp;quot;Hermann-2009&amp;quot;&amp;gt;PMID:19422428&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;PMID:18461349&amp;lt;/ref&amp;gt;. Type I keratins are generally smaller (average length 460 aa&#039;s), and acidic (isoelectric point 4.4-5.4), while type II keratins are longer (average length 545 aa&#039;s) and basic (isoelectric point 5-8.3). As noted, the size differences among keratins result from differences in the amino and carboxy terminals of the proteins &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Secondary structures of keratins==&lt;br /&gt;
[[Image:Keratin-secondary-structure-1000px.png|600px|right|thumb| Fig. 1. The locations of the &amp;amp;alpha;-helical domains (1A, 1B, 2A and 2B) in the central rod of a keratin subunit.]]&lt;br /&gt;
&lt;br /&gt;
The first model of alpha-helix was proposed by Pauling based on the crystallography of wool fibers &amp;lt;ref&amp;gt;PMID:12966187&amp;lt;/ref&amp;gt; that were shown to have long helical segments &amp;lt;ref&amp;gt;PMID:6072928&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Analysis of the first cytoskeletal keratin sequence revealed that this protein contains a central domain of ~310 residues that was predicted to be mostly in &amp;amp;alpha;-helix conformation &amp;lt;ref name=&amp;quot;Hanukoglu-1982&amp;quot; /&amp;gt;. By comparative analysis of the predicted structures of a type I keratin, a type II keratin, desmin and vimentin, Hanukoglu and Fuchs suggested that all IF proteins have a central ~310 residue domain that contains four segments in &amp;amp;alpha;-helical conformation that are separated by three short linker segments predicted to be in beta-turn conformation &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot; /&amp;gt;. This model has been confirmed by analysis of the crystal structure of segments of keratin coiled-coil &amp;lt;ref name=&amp;quot;Lee-2012&amp;quot; &amp;gt;PMID:22705788&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The structures of the head and tail domains of keratins are highly variable and have not been elucidated. Based on their sequences, these domains are predicted to be non-helical, probably forming globular structures that participate in interactions between subunits and other proteins in the scaffold of cellular cytoskeleton &amp;lt;ref name=&amp;quot;Hermann-2009&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Tertiary and quaternary structures of keratins==&lt;br /&gt;
&lt;br /&gt;
Keratin fibers are difficult to solubilize and so far it has not been possible to crystallize a whole keratin or a combination of keratin polymers. In the face of this difficulty, soluble segments of keratins have been generated both by proteolytic digestion and gene engineering to study the structural properties of keratins &amp;lt;ref name=&amp;quot;Parry-2007&amp;quot;&amp;gt;PMID:17521629&amp;lt;/ref&amp;gt; . &lt;br /&gt;
&lt;br /&gt;
As noted above, keratin filaments are composed of hetero-dimers. To express the long 2B segment of hetero-dimer of keratins K5 and K14, Lee et al. transformed two cDNAs into E. coli, isolated the heteromeric complex, and crystallized it. Structural analysis revealed a coiled-coil hetero-dimer structure of K5 and K14 intertwined around one another. These findings establish that keratin filament is composed of a coiled-coil hetero-dimer wherein the 2B segments are intertwined in parallel &amp;lt;ref name=&amp;quot;Lee-2012&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
All evidence to date indicates that the basic unit of a keratin filament is a left-handed hetero-dimer of a matched pair of keratins aligned in parallel. The ~10 nm wide keratin filament is assembled in several steps &amp;lt;ref name=&amp;quot;Hermann-2009&amp;quot; /&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
* Hetero-dimer: Formed by the twining of a matched pair of type I and type II keratins that form a coiled-coil.&lt;br /&gt;
* Tetramer: Formed by binding of two hetero-dimers in anti-parallel orientation. The exact mode alignment of the proteins, i.e. which helical domains lie side-by-side, is not known.&lt;br /&gt;
* Octamer: Formed by side-by-side binding of two tetramers containing overall eight keratin molecules. Such an octamer is named a &#039;&#039;protofibril&#039;&#039;.&lt;br /&gt;
* Unit length filaments (ULF): Formed by lateral - side by side - association of four protofibrils. In cross-section a protofibril has 32 keratin chains. ULFs are ~60 nm long and ~20 nm wide.&lt;br /&gt;
* Keratin filament: Formed by end-to-end association of ULFs. After assembly, the filament is compacted to a width of 10-12 nm.&lt;br /&gt;
&lt;br /&gt;
Thus, in a general picture, the helical domains of keratins form the backbone of the filaments, and the head and tail domains are involved in the end-to-end linking of the proteins.&lt;br /&gt;
&lt;br /&gt;
==Bonds that hold the coiled-coil structure==&lt;br /&gt;
&amp;lt;Structure load=&#039;3TNU&#039; size=&#039;600&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Fig. 2. Crystal structure of the 2B helical domain of coiled-coil dimer of type I keratin K14 (chain A) and type II keratin K5 (chain B) (residues Ser332-Gly421 of K14 and Thr382-Gly476 of K5). PDB ID: 3tnu. &lt;br /&gt;
Please click the green colored links in the text in order to view highlighted features of the structure.&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The basic building unit of keratin filaments is a hetero-dimer of a type I and a type II keratin. &lt;br /&gt;
The crystal structure of coiled-coil 2B helical domains of keratins K5 and K14, have revealed the bonds that are involved in tight binding of the two subunits &amp;lt;ref name=&amp;quot;Lee-2012&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Prior to enumeration of the bonds involved in keratin-keratin binding, it is essential to understand the structure of &amp;amp;alpha;-helix. The backbone of &amp;amp;alpha;-helix consists of the atoms that participate in the formation of the peptide bonds that connect the amino acid residues. The helix structure can be visualized as a cylinder around which the chain of residues are wrapped. The central axis of this cylinder defines the central axis of the helix. The R-groups of the residues are positioned perpendicular to the central axis. Thus, the helical surface is covered by the R-groups that protrude outward of the central axis of helix. &lt;br /&gt;
&lt;br /&gt;
Binding of two helical domains in an intertwined structure requires that the surfaces of the helical domains contain atoms or groups that participate in the binding of the two chains.&lt;br /&gt;
&lt;br /&gt;
Protein chains can bind to one another by several types of bonds:&lt;br /&gt;
&lt;br /&gt;
* Covalent bonds. Example: disulfide S-S bond between two cysteines.&lt;br /&gt;
&lt;br /&gt;
* Ionic bonds between charged residues with complementary charge. Example: Glu-Arg.&lt;br /&gt;
&lt;br /&gt;
* Hydrophobic interactions between hydrophobic residues. Example: Leu-Val.&lt;br /&gt;
&lt;br /&gt;
* Hydrogen bonds between suitable groups.&lt;br /&gt;
&lt;br /&gt;
In the 2B domains of keratins type I K14 and type II K5 shown in Fig. 2, there are two and a single cysteine respectively. These cysteines are far apart and cannot form disulfide bridges. &lt;br /&gt;
&lt;br /&gt;
* &amp;lt;scene name=&#039;55/559109/Cysteines/1&#039;&amp;gt;Click here to see the locations of the Cys in Fig. 2.&amp;lt;/scene&amp;gt; (Wait a few moments for change of scene)&lt;br /&gt;
&lt;br /&gt;
Thus, disulfide bridges cannot be responsible for the binding of K14 and K5. &lt;br /&gt;
&lt;br /&gt;
The second option is ionic bonds, or salt bridges between the two keratins. &lt;br /&gt;
* &amp;lt;scene name=&#039;55/559109/Acidic-residues/1&#039;&amp;gt;Click here to see the acidic residues, Asp and Glu in Fig. 2.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* &amp;lt;scene name=&#039;55/559109/Basic-aas/1&#039;&amp;gt;Click here to see the basic residues, Arg and Lys.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Both acidic and basic residues are seen to protrude mostly towards the outside surface of the two keratins and hardly in the space between the two keratins. The contact surface between the two keratins in a coiled-coil is located between the two keratins. Thus, the charged residues do not play a predominant role in the formation of the coiled-coil. In the K14-K5 dimer only 3-4 residues are involved in inter-strand interactions. Nonetheless, these residues are essential for normal function of keratin &amp;lt;ref name=&amp;quot;Lee-2012&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Hydrophobic residues: Main points of contact between chains ===&lt;br /&gt;
The third option noted above is hydrophobic interactions between the two keratins. &lt;br /&gt;
* &amp;lt;scene name=&#039;55/559109/Hydrophobic-aas/1&#039;&amp;gt;Click here to see the hydrophobic residues in Fig. 2.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It can be seen that the hydrophobic residues are predominantly located in the interface between the two chains and essentially occupy the space between these chains. Thus, hydrophobic residues that can associate with one another in the aqueous environment of cell are the main points of contact between the chains in the coiled-coil.&lt;br /&gt;
&lt;br /&gt;
As the two chains of keratins are intertwined in parallel, the contact points along the entire coiled-coil represent a seam along the two proteins. Coiled-coil structures are found in many types of proteins. In two-chained coiled-coil proteins hydrophobic residues appear in a periodic pattern that has been named a heptad-repeat &amp;lt;ref name=&amp;quot;Woolfson-2005&amp;quot;&amp;gt;PMID:15837514&amp;lt;/ref&amp;gt;. In a regular &amp;amp;alpha;-helix there are 3.6 residues per turn of the helix. In a left-handed coiled-coil there are 3.5 residues per turn. Thus, in a two chained coiled-coil there is a repeat pattern of seven residues that are represented by the letters a-b-c-d-e-f-g. Residues a and d in this pattern  are hydrophobic. These two residues define a hydrophobic flank for each protein. This periodic pattern was first reported on both type I and type II wool keratins &amp;lt;ref name=&amp;quot;PMID697726&amp;quot;&amp;gt;PMID:697726&amp;lt;/ref&amp;gt; and later observed on cytoskeletal keratins as well &amp;lt;ref name=&amp;quot;Hanukoglu-1983&amp;quot; /&amp;gt;. The crystal structures of the 2B segment of keratins K14 and K5 provided final confirmation for the role of these hydophobic residues in coiled-coil formation &amp;lt;ref name=&amp;quot;Lee-2012&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==3D structure of keratin==&lt;br /&gt;
&lt;br /&gt;
[[3tnu]] - hKRT14 residues 295-422 + hKRT5 residues 350-477 - human&amp;lt;br /&amp;gt;&lt;br /&gt;
[[3asw]], [[4f1z]] - hKRT10 peptide + clumping factor B&amp;lt;br /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Topic Page]]&lt;br /&gt;
[[Category:Featured in BAMBED]]&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049263</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049263"/>
		<updated>2014-10-30T16:37:47Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: Added colored blocks&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue ( &amp;lt;span style=&amp;quot;color:MediumBlue&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; )color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049262</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049262"/>
		<updated>2014-10-30T16:30:11Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom-in or zoom-out first click on the structure and then use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049261</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049261"/>
		<updated>2014-10-30T16:27:00Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green ( &amp;lt;span style=&amp;quot;color:GreenYellow&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ), and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049260</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049260"/>
		<updated>2014-10-30T16:13:04Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan ( &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;&amp;amp;#9608;&amp;amp;#9608;&amp;lt;/span&amp;gt; ) colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049257</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049257"/>
		<updated>2014-10-30T15:27:54Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in &amp;lt;span style=&amp;quot;color:Cyan&amp;quot;&amp;gt;cyan&amp;lt;/span&amp;gt; colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049256</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049256"/>
		<updated>2014-10-30T15:25:31Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049255</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049255"/>
		<updated>2014-10-30T15:23:29Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Contact region between Rossmann fold and FAD */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: &amp;lt;span style=&amp;quot;color:Gray&amp;quot;&amp;gt;Carbon&amp;lt;/span&amp;gt;; &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;Oxygen&amp;lt;/span&amp;gt;, &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;Phosphorus&amp;lt;/span&amp;gt; and &amp;lt;span style=&amp;quot;color:SlateBlue&amp;quot;&amp;gt;Nitrogen&amp;lt;/span&amp;gt;. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged &amp;lt;span style=&amp;quot;color:red&amp;quot;&amp;gt;oxygens&amp;lt;/span&amp;gt; of the two &amp;lt;span style=&amp;quot;color:DarkOrange&amp;quot;&amp;gt;phosphate&amp;lt;/span&amp;gt; groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049250</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049250"/>
		<updated>2014-10-29T18:19:46Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Contact region between Rossmann fold and NAD(P) */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: C: grey; O: red, P: orange and N: purple. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1i0z]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049249</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049249"/>
		<updated>2014-10-29T18:14:23Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: /* Extension of the beta sheet by additional strands */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: C: grey; O: red, P: orange and N: purple. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1ioz]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 5 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049248</id>
		<title>Rossmann fold</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Rossmann_fold&amp;diff=2049248"/>
		<updated>2014-10-29T18:01:55Z</updated>

		<summary type="html">&lt;p&gt;Israel Hanukoglu: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The Rossmann fold is a super-secondary structure that is characterized by an alternating motif of beta-strand-alpha helix-beta strand secondary structures. Hence this fold is also called a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold. The &amp;amp;beta;-strands participate in the formation of a &amp;amp;beta;-sheet.  The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure is commonly observed in enzymes that have dinucleotide coenzymes, such as FAD, NAD and NADP. &lt;br /&gt;
&lt;br /&gt;
==History== &lt;br /&gt;
[[Image:FAD-NADH-Structures.png|500px|right|thumb| Fig. 1. Structures of FAD and NADH in vertical orientation.]]&lt;br /&gt;
In 1973 Rao and Rossmann reported that a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold super-secondary structure commonly appears in a variety of nucleotide binding proteins, such as lactate dehydrogenase and flavodoxin &amp;lt;ref name=&amp;quot;R-R&amp;quot;&amp;gt;PMID:4737475&amp;lt;/ref&amp;gt;. In later studies this common structure was named after the author Michael G. Rossmann as the Rossmann fold. &lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was initially characterized in dinucleotide FAD and NADH binding proteins. Schulz et al. examining FAD binding domains of four enzymes noted that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold structure was associated with a specific consensus sequence of Gly-x-Gly-x-x-Gly at the region of the tight loop between the first &amp;amp;beta;-strand the &amp;amp;alpha;-helix &amp;lt;ref&amp;gt;PMID:7175934&amp;lt;/ref&amp;gt;. Wierenga et al. systematically examined more structures and derived rules for a fingerprint sequence named the &amp;quot;ADP-binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold&amp;quot; &amp;lt;ref&amp;gt;PMID:3959077&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In 1989, Israel Hanukoglu found that the NADPH binding &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in NADP dependent enzymes is characterized by a specific consensus sequence (briefly: Gly-x-Gly-x-x-Ala) that differs from the NADH binding site by one residue, with an alanine instead of the last glycine, and hypothesized that this single residue difference may determine the coenzyme specificity of the enzymes &amp;lt;ref name=&amp;quot;HI-1989&amp;quot;&amp;gt;PMID:2924777&amp;lt;/ref&amp;gt;. Richard Perham and his colleagues confirmed this hypothesis by site-directed mutagenesis of glutathione reductase and showed that coenzyme specificity could be re-engineered from NAD to NADP &amp;lt;ref&amp;gt;PMID:2296288&amp;lt;/ref&amp;gt;. The structural significance of the Ala for Gly substitution in NADP binding site was revealed by analysis of the crystal structure of NADP-dependent adrenodoxin-reductase &amp;lt;ref name=&amp;quot;Ziegler-1999&amp;quot;&amp;gt;PMID:10369776&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Dinucleotides that bind to Rossmann fold==&lt;br /&gt;
&lt;br /&gt;
The  &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is observed in numerous dinucleotide binding enzymes. The term &amp;quot;dinucleotide&amp;quot; may have two meanings: It may refer to an oligomer of two nucleotides such as A-G. In the present context, the term dinucleotide refers to a coenzyme that contains two distinct nucleotides. To emphasize the common structural aspects, the structures of two dinucleotides, FAD, NADH are shown in Figure 1. &lt;br /&gt;
&lt;br /&gt;
Note that both dinucleotides share at their base the common structure of adenosine diphosphate (ADP). The structure of FAD can be viewed either as a hybrid of AMP+FMN or as ADP+Riboflavin (see figure).&lt;br /&gt;
&lt;br /&gt;
NAD(P) is a two electron acceptor and donates the two electrons to FAD. The transfer of electrons takes place from C4 of NAD(P) to N5 of FAD. Each of these atoms is marked by its respective number in Figure 1.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Contact region between Rossmann fold and FAD==&lt;br /&gt;
[[Image:FAD-binding-sites.png|500px|right|thumb| Fig. 2. The FAD binding sites of D-amino acid oxidase ([[2e48]]) (residues 1-36) and glutathione reductase ([[3grs]]) (residues 21-50). FAD is shown in CPK mode.]]&lt;br /&gt;
In dinucleotide binding flavoproteins, FAD binding Rossmann fold is commonly located close to the amino terminus of the protein. Figure 2 shows the first Rossmann fold of two flavoproteins, D-amino acid oxidase ([[2e48]])&amp;lt;ref&amp;gt;PMID:17303072&amp;lt;/ref&amp;gt; and glutathione reductase ([[3grs]])&amp;lt;ref&amp;gt;PMID:3656429&amp;lt;/ref&amp;gt;. In both enzymes, the first &amp;amp;beta;-strand is followed by a tight loop that is connected to the N-terminal of the helix. The two highly conserved Gly residues in the consensus sequence are located in this turn to allow the sharp bending of the chain. At the end of the helix there is a wider turn that is followed by the second beta strand that runs parallel to the first strand.&lt;br /&gt;
&lt;br /&gt;
The FAD structure is shown in CPK format. The atoms can be identified by their colors: C: grey; O: red, P: orange and N: purple. The turn at &amp;amp;beta;-&amp;amp;alpha; border is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups. &lt;br /&gt;
{{clear}}&lt;br /&gt;
==Contact region between Rossmann fold and NAD(P)==&lt;br /&gt;
[[Image:NAD-binding-sites.png|500px|right|thumb| Fig. 3. NAD binding sites of 3-phosphoglycerate dehydrogenase ([[2p9e]]) (residues 152-182) and lactate dehydrogenase ([[1ioz]]). NAD is shown in CPK mode.]]&lt;br /&gt;
Figure 3 shows the Rossmann fold of two NAD binding proteins, 3-phosphoglycerate dehydrogenase ([[2p9e]])&amp;lt;ref&amp;gt;PMID:17459882&amp;lt;/ref&amp;gt; and lactate dehydrogenase ([[1i0z]]) (residues 21-53) &amp;lt;ref&amp;gt;PMID:11276087&amp;lt;/ref&amp;gt;. In enzymes that have just an NAD binding site, the site may be close to the N terminus of the protein as in lactate dehydrogenase. In flavoproteins that bind two dinucleotides, such as glutathione reductase and adrenodoxin reductase &amp;lt;ref name=&amp;quot;HI-1989&amp;quot; /&amp;gt;, the NAD(P) binding site appears in the middle of the protein.&lt;br /&gt;
&lt;br /&gt;
The &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold has a structure similar to the fold shown above for FAD.  For both enzymes, the first &amp;amp;beta;-strand is followed by a tight turn that is connected to the N-terminal of the helix. The same Gly-x-Gly-x-x-Gly consensus sequence appears at the turn between the first strand and the helix. Again, similar to FAD site, the turn region is in contact with the negatively charged oxygens (red colored) of the two phosphate (orange colored) groups.&lt;br /&gt;
{{clear}}&lt;br /&gt;
==A &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold example in ferredoxin reductase ==&lt;br /&gt;
&lt;br /&gt;
To illustrate a &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold in a complete protein, a 3D example (PDB ID: [[1f3p]]) is shown below. The example protein is a ferredoxin reductase from Pseudomonas that binds both an FAD and NADH &amp;lt;ref&amp;gt;PMID:11090282&amp;lt;/ref&amp;gt;. This enzyme binds NADH which transfers its two electrons to the FAD coenzyme of ferredoxin reductase. These electrons are then transferred to a ferredoxin that is an iron sulfur electron transfer protein. This ferredoxin then donates the electrons to an oxygenase that uses the electrons in a dioxygenase reaction.&lt;br /&gt;
&lt;br /&gt;
In Fig. 4 below, the two core &amp;amp;beta;-strands of the FAD binding site of the enzyme (PDB ID: [[1f3p]]) are shown in cyan colored &amp;quot;rocket&amp;quot; format, with a red colored helix in between the two strands.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;1f3p&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;left&#039; caption=&#039;Fig. 4. FAD binding site of ferredoxin reductase. PDB ID: 1f3p.&#039; scene=&#039;59/595757/Ferredoxin-reductase-fad/2&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following scenes illustrate some aspects of the structure. &lt;br /&gt;
&lt;br /&gt;
To rotate the molecule click and hold left mouse button. &lt;br /&gt;
&lt;br /&gt;
To zoom in or out use the mouse wheel.&lt;br /&gt;
&lt;br /&gt;
Click the following green links for the action indicated:&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly14/2&#039;&amp;gt;Display the first conserved glycine in space filling CPK format at the end of the first beta-strand of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-gly16/4&#039;&amp;gt;Display the second conserved glycine in space filling CPK format at the beginning of the helix of the FAD binding site.&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-fad-5-78/1&#039;&amp;gt;Display the structure of the residues 5-78.&amp;lt;/scene&amp;gt; Note that in between the second &amp;amp;beta;-strand and the third one there are four &amp;amp;alpha;-helical segments.&lt;br /&gt;
&lt;br /&gt;
: * &amp;lt;scene name=&#039;59/595757/Ferredoxin-reductase-full/3&#039;&amp;gt;Display the full structure of ferredoxin reductase.&amp;lt;/scene&amp;gt; Note that FAD has been colored a yellowish green, and NADP is shown also in CPK format that neighbors FAD.&lt;br /&gt;
&lt;br /&gt;
Note that in the full structure there are 5 &amp;amp;beta;-strands that form a &amp;amp;beta;-sheet in the FAD domain Rossmann fold.&lt;br /&gt;
{{clear}}&lt;br /&gt;
&lt;br /&gt;
==Extension of the beta sheet by additional strands==&lt;br /&gt;
[[Image:3-phosphoglycerate_dehydrogenase-2P9E-sheet.png|400px|right|thumb| Fig. 5. 3-phosphoglycerate dehydrogenase ([[2p9e]]) beta sheet in the NAD binding domain. The two beta-strands that form the core of the Rossmann fold are marked in dark-blue color.]]&lt;br /&gt;
As seen in the above example of ferredoxin reductase the &amp;amp;beta;-sheet that is in the nucleotide domain may have more than two strands. In many (but not all) proteins with &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold, the &amp;amp;beta;-strands may be part of a larger &amp;amp;beta;-sheet with up to seven &amp;amp;beta;-strands. Figure 4 shows five strands forming a &amp;amp;beta;-sheet in phosphoglycerate dehydrogenase ([[2p9e]]). Note that the segment connecting the second strand to the third is in coiled confirmation and not helical. Whereas the subsequent connections between strands include &amp;amp;alpha;-helix segments.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold ==&lt;br /&gt;
&lt;br /&gt;
A myriad of proteins include the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; Rossmann fold. Many of these proteins can be grouped in a hierarchy of families based on their sequence similarities &amp;lt;ref&amp;gt;PMID:11514662&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:8749365&amp;lt;/ref&amp;gt;,&amp;lt;ref&amp;gt;PMID:17658942&amp;lt;/ref&amp;gt;. Yet, many of these families do not show any significant sequence homology across families. &lt;br /&gt;
&lt;br /&gt;
The observation that the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; structure and its consensus sequence is observed in many seemingly unrelated proteins raises the question whether the origin of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold of all these proteins is a common ancestral sequence. Alternatively, there is also a possibility that this structure emerged in different proteins independently. &lt;br /&gt;
&lt;br /&gt;
The basic nucleus of the &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold is about 30 residues. In many proteins that do not share any significant sequence homology, there exists an extensive tertiary structural homology beyond this 30 residue segment, particularly in specific domains that bind dinucleotides. Therefore, the probability that this type of extensive structural homology evolved independently is very low. Thus, most likely &amp;amp;beta;&amp;amp;alpha;&amp;amp;beta; fold represents an ancient structure that left its vestige in numerous proteins. Certainly, this conclusion does not exclude the possibility of independent convergent evolution.&lt;br /&gt;
&lt;br /&gt;
==References== &lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Israel Hanukoglu</name></author>
	</entry>
</feed>